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Traumatic defects in articular cartilage can lead to joint disease and disability 
including osteoarthritis.  Because cartilage is unable to regenerate when injured, the field 
of tissue engineering holds promise in restoring functional tissue.  In this research, type II 
collagen was electrospun, cross-linked, and tested as scaffolds for supporting chondrocyte 
growth.  The mechanical, biochemical, and histological characteristics of the engineered 
tissue were assessed as a function of the electrospinning solution concentration (i.e. 
scaffold fiber diameter and pore properties) and as a function of the time in culture 
xiii 
(evaluated at 2, 4, and 6 weeks).  Fiber diameter had a linear relationship with 
concentration: mean diameter increased from 107 to 446 nm and from 289 to 618 nm, 
measured with SEM and permeability meter, respectively, with increasing concentration, 
from 60 mg/mL to 120 mg/mL.  Pore size revealed no relationship with concentration but 
mean values ranged in size from 1.76 to 3.17 µm2 or from 0.00055 to 0.0028 µm2, 
depending on the measurement technique.  Average porosity ranged from 84.1 to 89.1%, 
and average permeability was between 6.82x10-4 and 35.0 x10-4 D.  Histological analysis 
revealed a relatively high number of spherical cells, possibly indicating the expression of 
the chondrocyte phenotype.  However, there were very little glycosaminoglycans and type 
II collagen synthesized by the cells despite an increase in the cell density over time for the 
60, 80, and 100 mg/mL concentrations.  The mean values for peak stress (between 0.17 
and 0.35 MPa) and tangential modulus (between 0.32 and 0.64 MPa) for the mats are at 
least an order of magnitude less than that for native cartilage, while the mean values for 
strain at break (between 93 and 150%) for the mats are at least an order of magnitude 
greater than that for native cartilage.  The equilibrium stiffness for all concentrations 
decreased from week 2 to week 6 of tissue culture (which may correlate with increasing 
cell density); the 100 mg/mL concentration had the highest mean value (0.084 MPa at 
week 2) and the lowest mean value (0.010 MPa at week 6).  This research did not indicate 
any significant findings regarding the influence of concentration or culture time on 
chondrogenesis.  Because the cells appeared to grow on the surface of the scaffold but 
there was a lack of cell migration into the scaffold, the scaffold material may be sufficient 
to support chondrocyte growth but the scaffold physical design must be reconsidered.   
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Introduction 
 
 Articular cartilage is a thin layer of connective tissue covering synovial joint 
surfaces that functions to absorb energy, distribute loads uniformly between bones, and 
provide low-friction articulation.  Traumatic defects in articular cartilage can lead to joint 
disease and disability, which manifest as joint pain, stiffness, and a decrease in or loss of 
mobility.  Progressive degeneration (i.e. loss of normal structure and function) of articular 
cartilage can lead to osteoarthritis (OA), also known as osteoarthrosis or degenerative joint 
disease, in which the breakdown of the cartilage can lead to bones rubbing against each 
other [1, 2].  This disease affects an estimated 21 million people in the United States [2].  
OA is more prevalent in women, and its incidence increases with age.  In fact, about 10% 
of adults over the age of 50 years are afflicted with OA, and it is one of the leading causes 
of disability in the elderly [3].  It can occur in any synovial joint, but occurs most 
frequently in the knees, hips, hand joints, neck, and lower back [1, 2].  In the United States 
the cost of arthritis and related conditions including OA is almost $86.2 billion per year in 
medical care and indirect expenses, including lost wages and productivity [2].  Put another 
way, the total cost of arthritis (including OA) in the United States has been estimated to be 
over 2% of the gross domestic product [3].   
 Though the etiology of OA is not fully understood, the disease is characterized by a 
decline in the biomechanical properties of articular cartilage and a deterioration in the 
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balance between the chondrocyte anabolic (synthesis) and catabolic (resorption) processes 
which are essential for homeostasis [4].  Surgical attempts at repair can result in 
chondrocyte and tissue loss because disruption of healthy tissue may cause cell apoptosis 
and/or necrosis [5].  Currently, the main treatment is the replacement of the joint with 
metal prostheses that do not perform to the physical demand, wear out, loosen, or even 
break in situ [4].  To avoid joint replacement, clinicians and scientists have turned to tissue 
engineering for the repair of the cartilage prior to complete degeneration.  There are an 
abundant number of investigations into the tissue engineering of articular cartilage; 
however, thus far there have been no successes in the development of a tissue that exactly 
duplicates the material properties or durability of articular cartilage and thereby restores a 
normal joint surface.  Understanding the structure and function of healthy articular 
cartilage as well as the structural and biochemical alterations (i.e. matrix and cellular 
changes) that develop in OA are crucial in developing methods of repairing, restoring, or 
regenerating new tissue with the same function as the native tissue. 
 Tissue engineering, or regenerative medicine, is an interdisciplinary field that 
merges principles and innovations from engineering and life sciences for the purpose of 
addressing the improvement, repair, or replacement of tissue/organ function [6, 7].  Since 
its inception, the field has delved into three main areas: the injection of cells only, the 
development of encapsulated systems of cells, and the in vitro growth of cells in a scaffold 
(i.e. an artificial extracellular matrix) [8].  The latter is logical since every tissue or organ 
in our body is composed of parenchymal cells (functional cells) and mesenchymal cells 
(support cells) contained within an extracellular matrix (ECM) to form a dynamic 
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microenvironment.  Composition (i.e. biomaterials of synthetic or natural origin) and 
architecture of a tissue-engineered scaffold result in cell-environment interactions that 
determine the structure’s fate.  The tissue engineering of articular cartilage has developed 
out of the need to treat the chondral defects (on the surface of or within the cartilage).  
Since mature articular cartilage is aneural, avascular, and alymphatic, the tissue has a 
limited capacity for repair and regeneration [4, 9].   
 The design and development of a scaffold for articular cartilage tissue engineering 
is of interest in this research.  In general, the functions of the scaffold include the 
following: provide a defined space (with structural integrity) on/in which cells can migrate 
and proliferate, serve as a guide for tissue restructuring (i.e. new growth in vitro and/or 
incorporation in vivo), allow the diffusion of nutrients and wastes, and act as a cellular 
transducer of mechanical forces [8].  Biochemical and biomechanical considerations will 
be given to the tissue-engineered constructs, developed in this research study, designed to 
treat chondral defects.   
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Background 
 
Structure of Native Articular Cartilage Tissue 
 Articular cartilage is a thin layer of connective tissue covering synovial joint 
surfaces; it is the almost frictionless bearing surface for diarthrodial joints.  For humans the 
thickness of the cartilage layer may vary from 1 mm in finger joints to 6 mm on the 
articulating surface of the patella [10].  In normal physiologic conditions, articular cartilage 
is porous and highly hydrated.  With the application of a load, fluid flows in and out of the 
tissue, thereby resulting in changes in the mechanical, chemical, and electrical properties 
of the cartilage [11].  Articular cartilage functions to absorb energy, distribute loads 
uniformly between bones, and provide low-friction articulation.  Thus, to handle the forces 
imposed upon it, articular cartilage possesses a variable compressive stiffness and 
permeability (that depend on both current and previous loading conditions) as well as a 
low wear rate and a low coefficient of friction (ranging from 0.005 to 0.05) [10, 12].  Its 
function under a wide range of loading conditions ultimately depends on the structural 
arrangement of its major components (which differs within the tissue), the integrity of the 
extracellular matrix (ECM), and how these components respond to one another under 
loading.   
 Cartilage can be considered a fiber-reinforced composite material, that is both 
inhomogeneous and anisotropic, consisting of three major structural macromolecules 
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(collagen, proteoglycans, and glycoproteins) and cells known as chondrocytes (all of which 
are collectively considered the solid phase), water (considered the fluid phase), and solutes 
including ions and nutrients (sometimes considered a third phase, the ion phase).  In 
human articular cartilage, water accounts for more than 60% by wet weight, collagen 
comprises 60 to 80% of the dry weight or approximately 20% of the wet weight, and 
proteoglycans contribute 20 to 40% of the dry weight or about 7% of the wet weight [10, 
13].  Collagen and proteoglycan macromolecules are intertwined to form a solid structure 
that is anchored to the subchondral bone and through which water and solutes move freely 
to provide nourishment to chondrocytes as well as lubrication to the joint.  The 
cartilaginous ECM is depicted in Figure 1.  Molecular interactions among the structural 
macromolecules include collagen-collagen covalent (crosslinks) and noncovalent 
interactions, proteoglycan-proteoglycan noncovalent interactions, and collagen-
proteoglycan noncovalent interactions.  These molecular interactions achieve an 
immobilized network of collagen and proteoglycans (depending on shape and size) with 
pore sizes ranging from 25 to 75 Å that prevent the transport of large molecules through 
the tissue [14]. 
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Figure 1.  Illustration of collagen fibrils and proteoglycans in articular cartilage ECM [10]. 
 
 Type II collagen is the main collagen type found in articular cartilage, though types 
VI, IX, X, and XI can also be found in small amounts [13, 15].  A collagen fibril (Figure 2) 
consists of the basic tropocollagen structural unit composed of three procollagen 
polypeptide chains, or α chains (each designated α1(II) for type II collagen), which 
contain the repeating amino acid sequence of glycine-X-Y (in which X is frequently 
proline and Y hydroxyproline) and contain 990 to 1020 amino acids per polypeptide chain 
[16].  Each α chain is a left-handed helix, and the three chains are coiled about each other 
in a right-handed triple helix.  The tropocollagen molecules (rod-like in shape) are 
approximately 1.4 nm in diameter and 300 nm in length [14].  These molecules self-
assemble/polymerize outside of the cell into larger collagen fibrils.  Type II collagen fibrils 
exhibit an axial, periodic banding pattern of 64 nm separations (known as the D-periodic 
banding) [17].  Type I collagen fibrils form large fiber bundles that range in diameter from 
2 to 10 µm.  However, type II collagen fibrils do not form fiber bundles and range in 
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diameter from 20 to 200 nm [14, 18].  Intramolecular and intermolecular covalent 
crosslinks form between the α chains and between collagen molecules [14, 19].  Tensile 
stiffness and strength are the two most important contributions of collagen fibrils to the 
mechanical properties of the tissue as a whole [10].   
 
Figure 2.  Structure of collagen fibrils [14]. 
 
 Proteoglycans are aggregates composed of 100 to 200 monomers, known as 
glycosaminoglycans (GAGs), attached to a single backbone of hyaluronic acid, as shown 
in Figure 3.  Proteoglycans are entrapped within the collagen meshwork because of their 
size and electrostatic and frictional interactions with the collagen fibers (Figure 1).  Link 
proteins associate the monomers with the hyaluronic acid.  The two most abundant GAGs 
in articular cartilage that form proteoglycans (and in particular aggrecan) are chondroitin 
sulfate and keratan sulfate, with the former in more abundance typically than the latter 
depending on the zone [9].  Amounts, distribution, and composition vary among 
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individuals, and age- and disease-related changes in structure such as GAG monomer chain 
shortening and decreased aggregate size do occur [9, 14].   
 
Figure 3.  Structure of proteoglycan aggregate [9]. 
 
 GAGs are hydrophilic molecules with many negatively charged side chains that 
repel each other due to like charge, and thus fan out from the proteoglycan backbone 
giving the tissue a compressive resistance [9, 10].  As the proteoglycan is compressed and 
the side chains are brought into closer proximity, the effective repulsive force and charge 
density increases.  The negative charges attract the positive ions in the aqueous interstitial 
fluid, thereby leading to swelling of the tissue.  This swelling stresses the collagen fibers 
that restrain the proteoglycans such that the tissue can withstand the compressive stresses 
caused by matrix deformation during joint loading.  Thus, when a load is applied, the 
proteoglycans are compressed and the interstitial pressure increases; fluid flow then occurs 
through the matrix down the pressure gradient until equilibrium is reached and flow stops.  
Upon release of the load, the proteoglycans expand and fluid flows in the reverse direction 
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back into the matrix until the original shape (non-stressed) of the ECM is reestablished [9].  
As the interstitial fluid flows through the pores of the ECM, viscous frictional forces (drag 
forces) develop on the walls of these pores.  Cartilage deformation (compression and 
expansion) is determined by a balance of forces between the pressure exerted by 
proteoglycans and the tension generated within the collagen meshwork.   
 Articular cartilage consists of cells known as chondrocytes thinly dispersed within 
the ECM; the cells are more widely scattered within the ECM with increasing distance 
from the articular surface as depicted in Figure 4.  Chondrocytes, which arise from 
pluripotential mesenchymal stem cells, are metabolically active cells that produce, 
organize, maintain, and degrade cartilage matrix components [20].  The cells are, 
themselves, influenced by the ECM which responds to the loading conditions and the 
electrochemical signals imposed on the tissue (see Figure 5) [9, 10, 21].  During the 
development of cartilage, the cells proliferate rapidly and synthesize great amounts of 
matrix until maturation when the cells slow and cell density decreases.  In mature human 
articular cartilage, chondrocytes represent about 1% of the total volume, no longer divide, 
and decrease in density with age [10, 13, 15].  These cells do not form cell-to-cell contacts 
but surround themselves with ECM [9].  The structural matrix molecules maintain and 
direct tissue fluid flow through the tissue; thus, via diffusion and/or convection, nutrients 
are delivered to the chondrocytes by the synovial fluid carrying the nutrients from the 
interior lining of the synovial joint.  This solute transport is critical for chondrocyte 
nutrition as well as for the mechanical behavior of cartilage and joint lubrication [10].  
Chondrocytes vary in shape, and thus function, depending on the location within the 
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cartilage thickness, and the diameter can measure 10 µm or more at a circular cross-section 
[22].  In adult human articular cartilage, the flattened, discoidal cells (found more 
superficially) have been shown to have a reduced rate of protein synthesis; the spheroid-
shaped cells (found deeper within the cartilage thickness) are more actively involved in 
protein synthesis, particularly that to be processed into sulphated proteoglycans [22]. 
 
 
Figure 4.  A) Illustration of cell distribution within the ECM (white area is uncalcified 
matrix, black dots are cells) [23]; B) flattened, discoidal cells of the superficial zone and C) 
spheroidal cells from the deep zone [22]. 
 
 
Figure 5.  Diagram of the structure-function relationship of articular cartilage including 
chondrocyte and ECM interdependence [24]. 
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 Articular cartilage is divided into zones, or layers, based upon the inhomogeneous 
structural organization of the major tissue components throughout the depth of the tissue.  
Figure 6 gives a representation of the collagen organization within the zones.  Collagen 
varies with depth; it is found in greater concentrations nearer the surface, and collagen 
fibril diameter increases with depth [9, 10, 14].  Collagen fibrils are densely packed and 
run tangentially to the articulating surface in the superficial zone.  Fibrils are more 
randomly arranged in the middle zone but are oriented perpendicular to the surface in the 
deep zone where the fibrils are anchored in the tidemark region to the subchondral bone.  
The concentration of proteoglycans is maximal in the middle zone; GAG distribution is 
lowest at the surface, increases to a maximum in the middle zone, and decreases in the 
deep zone [14, 15].  Chondrocytes vary in morphology depending on the zone in which 
they are located (Figure 4 and Figure 7); in the superficial zone chondrocytes are flattened 
and elongated (discoidal), in the middle zone the cells are more spherical, and in the deep 
zone the cells are elliptical in shape and more vertically oriented [15, 22].   
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Figure 6.  Schematic of articular cartilage zones with collagen fibril organization [10] and 
graphical representations of the inhomogeneous distributions of water, proteoglycans, and 
collagen within those zones (superficial zone – SZ, middle zone – MZ, deep zone – DZ) 
[24]. 
 
 Within the cartilaginous zones, there are distinct regions of matrix around the 
chondrocytes in which the cells can establish and maintain an environment conducive to 
their needs (mechanically and metabolically) [9].  Figure 7 illustrates these matrix regions.  
The pericellular matrix is a thin layer of matrix that surrounds the cell and contains little or 
no fibrillar collagen.  Surrounding the pericellular matrix is the territorial matrix which can 
encase one chondrocyte or clusters of chondrocytes and their pericellular matrices; it 
consists of a dense network of fine collagen.  The interterritorial matrix establishes the 
mechanical properties of the cartilage; it surrounds the territorial matrix and forms the 
largest matrix region consisting of large collagen fibrils.   
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Figure 7.  Schematic of articular cartilage matrix regions (pericellular, territorial, and 
interterritorial) with chondrocyte and collagen fibril organization [25]. 
 
 
Biomechanical Properties of Articular Cartilage 
 In articular cartilage, collagen is responsible for the tensile and shear stiffness and 
strength, and proteoglycans are responsible for the equilibrium compressive stiffness of the 
tissue.  Since these proteins vary with depth and site within the tissue, it follows that the 
mechanical properties of the tissue are also depth- and site-dependent [26].   
 In uniaxial tensile measurements performed at a constant strain rate, the stress-
strain behavior is nonlinear, the curve of which consists of three areas of interest (shown in 
Figure 8).  The initial non-linear toe region is a result of the straightening of the coiled 
collagen fibrils at small extensions.  As tension increases, more fibrils are straightened and 
stretched; this is known as fiber recruitment.  The linear region involves the actual 
stretching of those fibrils into a parallel array, and the slope of this region gives an 
indication of the stiffness of the collagen fibrils as the tensile modulus (tangential 
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modulus) of the tissue.  After the linear region, the collagen fibrils fracture at the ultimate 
stress, which gives a measure of the strength of the collagen fibrils.  The mechanical 
properties of cartilage are dependent on depth, location (anterior, central, posterior), 
orientation relative to the predominant collagen fibril direction, and degree of 
degeneration.  Table 1 gives tensile properties of articular cartilage and collagen.  Tensile 
stresses develop in articular cartilage under compressive loading in the following manners: 
parallel to the surface in the superficial zone, various angles in the middle zone, and at 45º 
relative to the tidemark near the calcified region [10].   
 
Figure 8.  Typical stress-strain curve for articular cartilage tested in uniaxial tension [14]. 
 
 
Table 1.  Tensile properties of healthy hyaline cartilage and collagen fibers. 
 Tangential Modulus
(MPa) 
Peak Stress
(MPa) 
Strain at Break
(%) 
Hyaline Cartilage [27-29] 5-25 1.3-4.4 9.2-25.9 
Collagen [30]* 100-2900 5-500 5-50 
 *This is not type II collagen; these values are given for a general comparison. 
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 Articular cartilage displays both an elastic response and a time-dependent response 
to a perturbation; thus, the tissue is viscoelastic.  The viscoelastic properties of articular 
cartilage are primarily due to the frictional drag of the interstitial fluid flow through the 
permeable, porous, solid collagen-proteoglycan ECM [12, 14].  The compressive creep and 
stress relaxation behaviors are studied by applying theories describing the multiphasic 
nature of the tissue, including the solid phase consisting of the matrix of collagen fibrils, 
proteoglycans, and cells, the fluid phase consisting of interstitial water, and the ion phase 
[24, 31].  The model treats the tissue as a combination of a viscous fluid and an elastic 
solid.  Indentation experiments are typically used to test the viscoelastic properties of 
cartilage for several reasons: no special specimen preparations are needed, material 
properties can be determined in situ for native tissue, the whole joint surface can be tested 
easily, and neither the composition nor ultrastructure of the tissue is affected.  This simple 
setup involves compressing a specimen with a rigid, smooth cylinder, known as the 
indenter.   
 The creep response of articular cartilage to a constant compressive load is due to 
the flow of interstitial fluid (exudate) out of the matrix (Figure 9).  Upon initial application 
of the load, fluid leaves the matrix rapidly.  The straining of the fluid through the solid 
mesh creates a frictional drag.  With the loss of fluid pressure the collagen-proteoglycan 
matrix crushes and a compressive stress is developed within.  As time passes, flow 
gradually decreases and, at the point of equilibrium, when fluid flow ceases, there is a 
balance between the stress generated within the matrix and the applied load.   
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Figure 9.  General illustration and typical curve showing the deformation of articular 
cartilage for the creep response following an applied step load [32]. 
 
 Stress relaxation of articular cartilage occurs due to the redistribution of interstitial 
fluid within the matrix (Figure 10).  Following the application of a compressive 
deformation at a constant rate, high stress is initially created within the solid matrix near 
the point of application as the fluid is forced out.  As the deformation is held constant, fluid 
flows from and is redistributed within the matrix until an equilibrium compressive stress is 
established at which fluid flow ceases.   
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Figure 10.  General illustration and typical curve showing the stress response of articular 
cartilage for stress relaxation following an applied ramp displacement [14]. 
 
 Articular cartilage is considered a highly porous tissue with interconnected pores 
ranging in size from 25 to 75 Å [14, 32].  Permeability is a measure of resistive force at a 
given speed at which fluid flows through the pores, and it is inversely proportional to 
frictional drag exerted by the fluid.  Articular cartilage has a very low permeability, which 
means high frictional forces are generated within the pores.  The permeability of normal 
cartilage ranges from 10-16 to 10-15 m4/N·sec and that for degenerated cartilage is on the 
order of 10-14 m4/N·sec [12, 14, 32].  Permeability is strain dependent and decreases with 
increasing compressive strain; thus, excess fluid exudation is limited when compressive 
strain is prolonged.   
 
Articular Cartilage Damage and Potential for Native Repair 
 Diarthrodial joints withstand large ranges of loading conditions (very high loads 
and stresses typically at low operating speeds for an individual’s lifetime), but cartilage 
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sustains little wear and tear under normal conditions.  Mature articular cartilage is aneural, 
avascular, and alymphatic [9].  Based upon this structure, articular cartilage has a limited 
capacity for repair and regeneration of tissues in chondral defects (on the surface of or 
within the cartilage) [3].  In osteochondral defects, on the other hand, the void may be 
filled in with fibrocollagenous (composed mainly of fibrous collagen) and 
fibrocartilagenous (composed of parallel bundles of thick collagen fibers between 
chondrocytes, a low content of glycosaminoglycans, and small amounts of cartilage matrix 
only around chondrocytes) tissues, but hyaline cartilage repair tissues are rarely seen [33].  
Though healthy chondrocytes may proliferate and synthesize proteoglycans (in acute 
cartilage injuries), the cells do not migrate into and do not fill in the defects caused by 
injuries with newly synthesized matrix [9].  Damage to articular cartilage does not elicit an 
inflammatory response.  It is proposed that the lack of pluripotent marrow cells (i.e. 
parenchymal cells that are present in the bone) in the cartilage and the absence of a fibrin 
clot (i.e. the natural provisional scaffold) for the cells to migrate into are the reasons tissue 
regeneration does not occur in chondral defects [33].  In situations of trauma or overuse or 
misuse, degenerative changes may occur that can eventually lead to the development of 
OA [1].  Early changes seen in OA include loss of proteoglycans from the ECM, a 
disruption in the collagen fiber network due to excessive mechanical stresses (such as 
loosening) in the superficial zone extending into the transitional zone (considered fraying 
or fibrillation of the cartilage), changes in proteoglycan properties (molecular structure, 
disaggregation, etc.), abnormal proteoglycan expansion leading to excessive tissue 
swelling (and increased water content), changes in the collagen-proteoglycan interactions, 
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and remodeling of subchondral bone [1, 5, 10].  Macroscopically, softening, fibrillation, 
and erosions can be seen while clefts, loss of cartilage layers, cellular necrosis, cell 
cloning, and tidemark duplication are seen histologically; additionally, the superficial zone 
seems to be affected first in early OA [3].  Figure 11 presents two scanning electron 
micrographs (SEMs) showing the surfaces of healthy human articular cartilage (densely-
packed, randomly-arranged collagen fibrils and fine pores) and osteoarthritic human 
articular cartilage (degenerative characteristics including tears).  The presence of any 
surface irregularities on articular cartilage can have tremendous consequences, such as 
effects on friction (i.e. lubrication) and on the rate of further degradation.  Figure 12 
presents histological sections of healthy and osteoarthritic human articular cartilage.   
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Figure 11.  Scanning electron micrographs of the surfaces of human articular cartilage 
from a healthy specimen (top) and an osteoarthritic specimen (bottom); X3,000 
magnification [34]. 
 
 
Figure 12.  Histological sections of adult (A) healthy articular cartilage and (B) articular 
cartilage in early OA (showing clefts, cellular cloning, and cell necrosis) [3]. 
21 
 Matrix metalloproteases (MMPs) are the family of proteolytic enzymes responsible 
for the digestion of the cartilage ECM in OA [3].  It is believed that type II collagen is 
digested by collagenase-1 (MMP-1) and collagenase-3 (MMP-13), and stromelysin-1 
(MMP-3) and aggrecanase-1 (ADAMTS-4) are the primary MMPs involved in 
proteoglycan degradation.  Homeostasis of the MMPs in joints is normally maintained by 
such physiologic activators as cathepsin B and plasminogen activator/plasmin and by their 
inhibitors known as tissue inhibitors of MMPs, or TIMPs.  Researchers have found an 
imbalance between the amounts of MMPs and TIMPs in OA tissues [3].   
 The most obvious deleterious effect of any sort of damage to articular cartilage is 
the loss of matrix proteoglycans, though the other components may suffer effects as well 
[5, 9].  There is a threshold of damage at which chondrocytes can replace the 
proteoglycans lost (as long as the collagen matrix remains intact and the chondrocytes are 
healthy), but beyond which the cartilaginous damage is irreversible [9].  The quality of the 
minimal amount of repair depends on the extent (volume or surface area of tissue injured) 
and severity of the damage as well as the location of injury.  Evidence has shown that 
smaller defects heal better than larger defects [9].  Causes of damage can include a variety 
of means: trauma (surgical or otherwise) to the synovial membrane, infection or 
inflammatory diseases, prolonged joint immobilization, mechanical disturbances 
(penetrating injuries even into subchondral bone, blunt trauma, frictional abrasion, 
concentrated loads), some anti-inflammatory agents, and anything that kills chondrocytes 
and disturbs the matrix. 
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 Repair is defined as the “replacement of damaged or lost tissue with new tissue” 
[9].  The two main symptoms propagating the search for ways to repair cartilage are the 
pain and disability.  Success of repaired tissue is described as that which restores normal 
pain-free motion of the joint and prevents deterioration of the joint.  Doctors, scientists, 
and engineers operate under the assumption that the repaired/regenerated tissue must have 
the same structure and function (including composition, material properties, and durability) 
as native tissue [9, 35].   
 There are numerous autologous and allogeneic therapies and tissue 
grafts/transplantations that have been investigated for the therapeutic treatment of articular 
cartilage defects, all of which have had varying results [1, 4, 5, 13, 20, 36-41].  Autologous 
implants have involved the use of filling cartilage defects with grafts of the lining tissues 
perichondrium and periosteum; these grafts have resulted in complications including 
incomplete filling with a tissue that has only some cartilaginous characteristics, 
detachment of the graft, and graft ossification.  In mosaicplasty, osteochondral plugs from 
low weight-bearing areas on the femoral condyles are removed and press-fitted into the 
cored out damaged areas of the cartilage; though these autografts may result in temporary 
pain relief and restoration of function, they have not been shown to possess longevity, they 
may be damaged by the insertion method, and a loss of chondrocytes can result at the 
donor site.  Cadaver allografts have been utilized to restore function with minimal pain; 
though they offer the benefit of not creating new pathological sites, they do not become 
integrated with the surrounding tissue and there are always the concerns of immunological 
responses and disease transmission.  The delivery of cells-only to the defect site, known as 
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autologous chondrocyte implantation (ACI) or autologous chondrocyte transplantation 
(ACT), is clinically available in the United States; such an approach involves filling a 
defect with autologous chondrocytes or mesenchymal stem cells and suturing a flap of 
periosteum over the defect to hold the cells in place.  Drilling and debriding can provide 
immediate relief of symptoms, but fibrocartilagenous tissue forms with a poor outcome 
long-term [42].  Surgical penetration of the subchondral bone, which disrupts the blood 
vessels, leads to the formation of a fibrin clot, and enables the migration and proliferation 
of mesenchymal cells (which can differentiate into cells with chondrocytic morphology) as 
well as the potential release of growth factors, has been shown to result in the stimulation 
of new surface tissue, though this is again fibrocartilagenous tissue [1].  Since 
transplantation involves complications (such as insufficient donor tissue supply, donor site 
morbidity, and difficulty obtaining correct three-dimensional shapes) and artificial 
prostheses can lead to the undesirable results of infection, protein deposition, and immune 
responses [42], other approaches for repair are under investigation. 
 
Tissue Engineering of Articular Cartilage 
 Due to the avascular nature and relatively low cellular content of articular cartilage 
and, hence, the inability of cartilage to regenerate when injured, tissue engineering holds 
much promise in the repair of larger cartilage defects.  Most often the tissue engineering of 
articular cartilage involves the use of a scaffold onto which articular chondrocytes or their 
precursor cells are seeded in order to grow a three-dimensional tissue that can be implanted 
into the joint defect.  Additionally, growth factors may be incorporated into scaffolds (with 
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or without cells) to encourage tissue growth.  The goal is to have in vitro chondrogenesis 
within the cell-scaffold complex that matches native in vivo chondrogenesis.  This in vitro 
chondrogenesis is dependent upon cell type, initial cell density, scaffold characteristics, 
and culture conditions.  Tissue engineers of articular cartilage have agreed that the way to 
achieve this in vitro chondrogenesis is by mimicking the native tissue’s mechanical and 
biochemical properties [35]. 
 Cell proliferative capacity, phenotype stability, and immunogenicity must be 
considered when selecting the cell type to use in cartilage tissue engineering.  
Chondrocytes are used as in ACI/ACT, but these cells exhibit replicative senescence and, 
thus, their in vitro expansion may be limited.  When chondrocytes are expanded in 
monolayer, the cells lose their differentiated phenotype and transform into a fibroblastic 
morphology characterized by a decrease in the expression of type II collagen and 
proteoglycans and an increase in the expression of type I collagen [43, 44].  Mesenchymal 
stem cells (MSCs), multipotent progenitor cells prevalent in adult bone marrow with the 
capacity to differentiate into chondrocytes among other cell types, are of extreme interest 
because isolation, expansion, and differentiation into chondrogenic cells would eliminate 
the need to harvest chondrocytes/cartilage from the patient.  MSCs have been induced into 
the chondrogenic pathway with transforming growth factor-beta (TGF-β).   
 An ideal characteristic of a scaffold is the support of cells at the early stage of 
tissue growth and then the slow degradation of the scaffold (into nontoxic products) as new 
ECM becomes functional.  A wide variety of natural and synthetic materials have been 
investigated to accomplish this goal.  Natural materials are of interest in scaffold materials 
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for cartilage tissue engineering [4, 5, 36, 38, 42, 45] because these materials may contain 
or present the biochemical and ultrastructural characteristics required by cells for proper 
cell-ECM communication.  Fibrin, the major component of wound site clots, has been 
investigated in a polymerized form and as a glue.  Agarose and alginate, linear 
polysaccharide polymers extracted from seaweed, form hydrogels that have performed 
well in filling the defects.  Since collagen is the main component of the native ECM and it 
can be degraded by the cells, it is very popular as a scaffold; collagen gels, sponges, and 
fibrous meshes have been investigated.  Cross-linking can be used to increase degradation 
rates and tailor mechanical strength.  Collagen gels have been shown to maintain 
chondrocyte phenotype, and collagen sponges can stimulate collagen synthesis.  Chitosan 
hydrogels and molded porous structures are also under investigation as defect-filler 
materials.  Hyaluronan, which makes up 1 to 10% of cartilage glycosaminoglycans and 
plays an important role in cell attachment, hydration, and matrix synthesis, has been used 
to prepare scaffolds to mimic embryonic cartilage tissue formation.  Natural polymers may 
interact with cells in a more native manner, but typical problems with natural materials 
include batch-to-batch quality variability and weak structural properties [42].   
 Of the synthetic materials utilized as scaffolds for articular cartilage tissue 
engineering, the most widely used are the polyesters poly(lactic acid) (PLA), poly(glycolic 
acid) (PGA), and their copolymers [4, 5, 36, 38, 41, 45, 46].  In particular, PGA scaffolds 
have been shown to improve proteoglycan synthesis by chondrocytes [42, 47].  
Advantages to using synthetic materials include the ability to customize the polymer 
chemistry and, hence, the mechanical properties which, in turn, can result in improved 
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retention at the implantation site; controlled polymer degradation; more consistent quality; 
and tailored surface morphology.  Frequently, different materials (synthetic and natural) 
are combined to create scaffolds with tailored biochemical and mechanical characteristics.  
These scaffolds can be produced in the forms of foams, hydrogels, woven and nonwoven 
fiber meshes, or multi-phase structures (e.g. fibrous PLA combined with an alginate gel) 
[36, 48].  Polyester scaffolds have, unfortunately, demonstrated poor cell attachment, 
difficulty in manufacturing, and some inflammatory reactions in vivo.   
 Numerous studies have compared the responses of cells, particularly chondrocytes, 
to various scaffold materials in different culture environments, and thus have attempted to 
demonstrate the effects on cellular metabolism.  Grande et al. cultured chondrocytes on 
non-woven PGA (fibers 14 µm in diameter and 200 µm pores), woven PLA-PGA 
copolymer (Vicryl, 210 µm pores), knitted nylon (90 µm pores), and non-woven fibrillar 
type I collagen (100 to 300 µm pores) in static culture and in a closed-loop recirculating 
system.  The greatest number of cells attached to the collagen scaffold, while the least 
number attached to the nylon scaffold; all of the synthetic materials displayed cells of both 
fibroblastic and chondrocytic morphologies after 5 weeks of culture.  Additionally, the 
synthetic materials resulted in the increased rate of production of proteoglycans compared 
to the collagen scaffold, but collagen scaffolds stimulated the synthesis of collagen 
compared to the others [47].  Buschmann et al. prepared agarose gel scaffolds for 
chondrocyte seeding, and they reported that cell density, GAG concentration, and stiffness 
of the engineered tissue (following 5 week culture) was about 25% that of calf articular 
cartilage [49].   
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 Though scaffolds in the form of gels and glues are conducive to cell growth [41], 
most are mechanically weak and cannot withstand handling.  There are a number of 
fabrication techniques routinely employed to create three dimensional scaffolds with 
desired features including high porosity, pore interconnectivity, large surface area, and 
mechanical integrity [50].  In fiber bonding a non-woven mesh of polymer fibers is 
chemically treated and then melted to bond the fibers at their cross-points.  Similarly, in 
spray casting external fibers of a non-woven mesh are bonded at their cross-points by a 
coating of polymer when they are sprayed with a polymer/solvent solution and the solvent 
is removed (the solvent does not dissolve the fibers of the mesh).  Solvent casting and 
particulate leaching involve the use of particulates that are dispersed within a polymer 
solution that is cast on a surface; the solvent is removed and the particulates are leached 
from the remaining polymer solid.  For membrane lamination, multiple scaffolds 
(membranes) are created using solvent casting and particulate leaching and then bonded 
together (on top of one another) to form a more complex three dimensional structure.  Melt 
molding involves heating a polymer solution (placed in a mold) containing particulates 
above its glass transition temperature followed by leaching of the particulates in a water 
bath.  As another fabrication technique, polymers can be extruded into tubular shapes or 
fibers via heating and applying pressure to push the heated polymer through an opening; 
non-woven, fibrous meshes can be created or solvent casting and particulate leaching can 
be combined with extrusion to create porous solid structures.  One form of gas foaming 
involves the saturation of polymer discs with carbon dioxide in a high pressure chamber 
followed by a rapid drop in pressure to ambient level.  Freeze drying is typically performed 
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on a frozen emulsion of two immiscible, but homogenized solutions in a lyophilizer via the 
process of sublimation.  Phase separation can be performed on liquid-liquid or liquid-solid 
preparations via such techniques as vacuum drying or freeze drying.  Finally, in 
electrospinning a charged polymer solution is passed through an electric field; as the 
solvent evaporates, a dry polymer fiber is collected to form a non-woven, fibrous mesh.  
Many of these techniques involve the use of toxic solvents, require significant amounts of 
time, cannot be performed with bioactive molecules, may result in closed pore 
morphology, or are unable to form complex three dimensional shapes; thus, many of these 
techniques do not lend themselves easily or economically to mass production. 
 Though the choice of scaffold material and fabrication technique have not been 
agreed upon, there is consensus that mechanical stimuli are necessary in the tissue 
engineering of articular cartilage though these details are still to be determined [4, 15, 35, 
51, 52].  Chondrocytes in native articular cartilage experience mechanical stimulation 
including compressive and shear forces and hydrostatic pressure.  Investigations in vitro of 
mechanical stimulus/response mechanisms include the effect of hydrostatic pressure on the 
protein production of cells grown in monolayer, the effect of direct compression of cell-
seeded scaffolds on proteoglycan and collagen production, and the effects of low-shear on 
protein production as a result of more effective diffusion of oxygen and nutrients into the 
scaffolds within the culture environments.  For example, dynamic, direct compression has 
been found to increase ECM synthesis and produce greater equilibrium moduli [35].  
Buschmann et al. exposed agarose gel scaffolds with chondrocytes to static (maintained at 
a specific thickness) and dynamic (a sinusoidal displacement with a specific amplitude) 
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compression up to 47 days to study the effects on protein synthesis rates; dynamic 
compression showed enhanced synthesis of GAGs and collagen [53].  Carver and Heath 
designed a perfusion system that intermittently compressed the chondrocyte-seeded PGA 
scaffolds; in general, the compression reduced cell proliferation and increased GAG and 
collagen synthesis within the scaffolds [54].   
 Bioreactors (in which cell-seeded scaffolds are cultured) have become quite 
popular in the tissue engineering of articular cartilage since the systems allow the control 
of in vitro culture conditions (including temperature, pH, oxygen concentration, pressure, 
and biochemical factors in the growth medium) and provide low-shear mechanical stimuli 
to cells [4, 13, 41, 52, 55-58].  For example, it has been shown that dynamic deformational 
loading or shear of chondrocytes within a three-dimensional structure results in GAG 
synthesis, and strain of mesenchymal progenitor cells within a collagen gel results in cell 
alignment and oriented collagen fibers [57].  Theoretically, a bioreactor can provide an 
initial uniform distribution of cells to be seeded onto the scaffolds placed within the 
bioreactor chamber.  Additionally, mass transport can be controlled to more directly 
influence cell function.  Vunjak-Novakovic et al. have performed extensive bioreactor 
studies of tissue engineered articular cartilage to reveal that the biochemical and 
mechanical properties of the tissue can be controlled by the duration and conditions of the 
bioreactor culture [55, 56, 59, 60].  In most of the studies, the scaffolds consisted of 
extruded, biodegradable PGA in a non-woven mesh structure (13 µm fiber diameters), 
measuring 5-10 mm diameter x 2-5 mm thick, with a typical void volume of 96%.  An 
initial seeding density of 5-7x106 freshly isolated chondrocytes per scaffold was typical, 
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and seeding was performed over 3 days in well-mixed spinner flasks.  Cell-polymer 
structures as well as harvested cartilage explants were placed into static flasks (no 
movement of scaffolds or medium), mixed flasks (no movement of scaffolds, but turbulent 
flow of medium), or rotating bioreactors (scaffolds suspended in laminar flow of medium) 
for culture for 6 weeks (standard culture conditions, with 5-10% CO2, were maintained 
within the incubators and 50% of the culture medium was replaced every 2-3 days).  An 
increase in GAG content and total collagen amount was seen over the 6 weeks for the cell-
scaffold structures in all three culture conditions, but the hydrodynamic environment of the 
rotating bioreactor demonstrated the largest increase compared to the other two culture 
conditions due to the mechanical stimulation provided to the cells.  The primary 
determinant of GAG and collagen content in these bioreactor studies was the presence of 
mixing within the culture vessels as opposed to the intensity of the mixing [61].  Novel 
bioreactors have been designed and developed by other groups with the goals of lowering 
the shear stress, allowing more controlled gas and nutrient exchange, and creating a large 
growth area to give room for more or larger scaffolds [57].   
 There are a number of proteins that have an influence on the differentiation and 
phenotypic expression of chondrocytes, including the TGF-β family, insulin-like growth 
factor (IGF-1), bone morphogenic proteins (BMPs), fibroblast growth factors (FGFs), and 
epidermal growth factor (EGF) [35, 42].  This diverse group of growth factors influences 
chondrogenesis of mesenchymal cells during embryonic development [4].  These 
molecules can have the following effects: proliferation induction, increased ECM synthesis 
and deposition, and chondrogenesis induction by MSCs.  Both TGF-β1 and IGF-1 can 
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stimulate both GAG synthesis and type II collagen synthesis.  Incorporation of such 
growth factors or other biological signaling moiety (such as the cell adhesion peptide 
RGD, or arginine-glycine-aspartic acid) gives the scaffold the biological activity to elicit 
desired cellular responses.   
 
Electrospinning in the Tissue Engineering of Articular Cartilage 
 Many of the scaffolds tested thus far have not resulted in regenerated tissue with 
the biochemical or morphological properties of native normal articular cartilage [36].  Due 
to limited availability of suitable donor tissue and the desire to match the mechanical 
properties of the implant with the mechanical requirements in vivo, investigators have 
recently become interested in designing electrospun scaffolds for the tissue engineering of 
articular cartilage.   
 Electrospinning is a process that was first conceived in the late 19th century by Lord 
Rayleigh, with the first US patent being issued in 1934 to Formhals [62, 63].  In 
electrospinning (Figure 13), a polymer solution within a reservoir is charged via 
application of an electric potential (kilovolt range) to an electrode (nozzle) attached to the 
reservoir.  A ground target is placed some distance away from the nozzle such that an 
electric field is created.  As the intensity of the electric field is increased, the force of 
electrostatic repulsions in the solution exceed the force of its surface tension and a liquid 
jet is formed at the nozzle tip; the conical shape of solution seen at the nozzle tip is known 
as the Taylor cone.  The liquid jet is ejected from the nozzle and attracted to the grounded 
target; the trajectory of the jet is dictated by the electric field and the charges within the 
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polymer.  If there are significant chain entanglements within the polymer solution and the 
solvent is relatively volatile, evaporation of the solvent yields the formation of a fiber.  The 
fiber collects on the target to form a fibrous, non-woven fabric/structure.  If the process is 
at steady state, then electrospinning is producing a single, continuous fiber that is 
collected.  The adjustment of several electrospinning parameters allows for further control 
and refinement of scaffold characteristics [64, 65].  Altering the concentration or molecular 
weight (and, hence, viscosity and polymer chain entanglements) of the polymer solution 
affects fiber diameter: the higher the concentration the larger the diameter of the fibers.  
Varying the geometry of the grounded target will change the size and shape of the 
electrospun scaffold.  Scaffold thickness is dependent on the volume of polymer solution 
electrospun: greater volumes equate to thicker specimens.  Fiber alignment is controlled by 
rotation of the grounded target: a high rotational speed will draw the fibers into a highly 
aligned formation parallel to the direction of rotation, while low rotational speeds allow the 
fibers to collect randomly on the grounded target.  Structures composed of multiple 
polymeric components can be created by electrospinning the components simultaneously 
from the same nozzle or from different nozzles (resulting in one layer) or one at a time on 
top of one another to create multiple layers [66].   
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Figure 13.  Schematic of the electrospinning apparatus showing the basic components. 
 
 Type II collagen was first electrospun for potential use in cartilage tissue 
engineering by Matthews et al. since type II collagen accounts for 50-80% of the dry 
weight of articular cartilage.  Type II collagen from chicken sternal cartilage dissolved in 
1,1,1,3,3,3-hexafluoro-2-propanol (HFP) was electrospun at 40 mg/mL and 100 mg/mL, 
which resulted in fiber diameters of 110 ± 90 nm and 1750 ± 900 nm, respectively.  The 
collagen scaffold was fixed in glutaraldehyde vapors prior to seeding with normal human 
articular chondrocytes.  Histological analysis showed that the cells were evenly distributed 
across the scaffold thickness.  After two weeks in culture in a rotary cell culture system, 
there was a nearly confluent layer of cells on the external seeded surface, and there was 
some degree of remodeling of the matrix [67].  Shields et al. electrospun type II collagen in 
HFP, cross-linked the scaffolds with glutaraldehyde vapor, performed mechanical testing 
of dry uncross-linked samples, and seeded the cross-linked samples with adult human 
articular chondrocytes (scaffolds were statically cultured for 7 days).  Average fiber 
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diameter was 496 nm for the uncross-linked scaffolds and 1.6 µm for the cross-linked 
scaffolds.  Tensile mechanical properties of the uncross-linked samples were as follows: a 
tangential modulus of 172.5 ± 36.1 MPa, an ultimate tensile strength of 3.3 ± 0.3 MPa, and 
an ultimate strain of 0.03 ± 0.005 mm/mm.  Chondrocytes were shown to adhere and 
infiltrate the thickness of the scaffolds [68].   
 Other materials have also been electrospun for the tissue engineering of cartilage.  
Bhattatai et al. electrospun alginate-poly(ethylene oxide) (PEO) in water solutions to create 
scaffolds with mechanical properties within the range of articular cartilage following cross-
linking with calcium chloride [69].  Cellular compatibility was investigated (3 days) with 
chondrocytes and resulted in the cells attaching well, forming clusters, and maintaining 
their round morphology [69].  Li et al. electrospun poly(ε-caprolactone) (PCL), at 0.14 
g/mL in tetrahydrofuran (THF) and dimethylformamide (DMF) (700 nm diameter fibers), 
to investigate the responses of fetal bovine chondrocytes in vitro [70].  The chondrocytes 
on the PCL scaffold appeared round and adhered to and extended along the fibers; the cells 
expressed cartilage-associated ECM genes.  PCL was found to provide better mechanical 
and structural properties with a better degradation profile for culturing these cells.  Results 
showed that cellular proliferation and differentiation were controlled by the morphology of 
the scaffold and the composition of the medium which support the differentiation state of 
the cells.  This is as opposed to cultures in monolayers which do not maintain the 
chondrocytic phenotype [70].  In another study, Li et al. electrospun PCL again at 0.14 
g/mL in THF and DMF, but the scaffolds were seeded with human bone marrow derived 
mesenchymal stem cells (MSCs) and maintained in medium supplemented with 
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recombinant human transforming growth factor-β1 (TGF-β1) prepared to promote 
chondrogenesis [71].  In the presence of TGF-β1, the three-dimensional PCL scaffold 
induced greater expression of sulfated glycosaminoglycan synthesis and collagen types II 
and IX were up-regulated; the cell count remained constant after 21 days.  Chondrogenesis 
was induced and the electrospun scaffold (cell-matrix interactions) proved more effective 
at supporting chondrogenesis than the more commonly used method of MSC 
chondrogenesis in a high density cell pellet culture (cell-cell interactions) [71].  Recently, 
Li et al. electrospun six different poly(α-hydroxy ester) polymers, including PGA, poly(L-
lactic acid) (PLLA), poly(D,L-lactic acid) (PDLLA), the copolymer poly(D,L-lactic-co-
glycolic acid) at two ratios (50:50 and 85:15) (PLGA5050 and PLGA8515), and PCL.  
These polymers were electrospun from HFP for PGA (4 g/40 mL), a 50:50 mix of THF 
and DMF for PDLLA (4 g/11.4 mL), PLGA5050 (4 g/11.4 mL), PLGA8515 (4 g/13.4 
mL), and PCL (4 g/28 mL), and a 10:1 ratio of chloroform to DMF for PLLA (4 g/27.5 
mL).  Tensile testing was performed on dry samples with the following results.  
PLGA5050 and PGA scaffolds had the highest Young’s modulus and PLLA and PCL were 
the least stiff scaffolds.  PLGA5050 and PGA also had the highest values of yield stress, 
while PCL had the highest value of yield strain.  The different materials had varying 
degradation rates, with PCL and PLLA scaffolds maintaining their structure for the full 42 
days of incubation in PBS at 37ºC.  PDLLA, PLGA5050, and PLGA8515 all shrank after 3 
days, with PLGA5050 showing the most severe shrinkage.  For the PLLA and PCL 
scaffolds, in which degradation occurred the slowest, the seeded chondrocytes adhered to 
the fibers and began migrating through pores during the 7 days of incubation.  Results 
36 
showed that the properties of the electrospun fibers are dependant upon the polymer used 
[72].  Shin et al. electrospun 25 wt% solutions of 75:25 PLGA in a 1:1 mixture of DMF 
and THF resulting in a mean fiber diameter of 550 ± 150 nm and a porosity of 80.68%.  
Tensile testing of dry samples revealed the following mechanical properties: a mean tensile 
modulus of 95.53 ± 6.60 MPa, a mean ultimate tensile stress of 3.10 ± 0.49 MPa, and a 
mean ultimate tensile strain of 78.95 ± 12.63 %.  There was little degradation of this 
scaffold even after 7 weeks of incubation.  Their conclusion is that these mechanical 
properties, though not quite equivalent to those of cartilage, would be able to be implanted 
and can support tissue regeneration [73].  1% (w/v) chitosan was mixed with a small 
amount of PEO in an undisclosed solvent and electrospun by Subramanian et al.  Tensile 
testing of wet samples gave results of 2.25 ± 0.67 MPa for the modulus and 0.63 ± 0.16 
MPa for the ultimate tensile strength.  Following cell seeding, canine chondrocytes 
attached to the fibers of the electrospun scaffold, and it was concluded that cell growth was 
not inhibited by the electrospinning reagents or process [74].   
 These investigations were aimed at evaluating the usefulness of different 
electrospun materials for the application of articular cartilage tissue engineering.  A variety 
of materials, natural and synthetic polymers, can be electrospun and the properties of the 
resulting scaffolds can be modulated via polymer selection, concentration, and blending.  
Thus far, a number of investigators have shown positive and promising results with 
chondrocyte-scaffold interactions and scaffold mechanical properties.   
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Scaffold Design 
 The native ECM network creates a dynamic, three-dimensional microenvironment 
in which cells are maintained.  The ECM functions as both the structural matrix for tissue 
as well as the regulator of cellular activity via cell-ECM communications.  Signals are 
transmitted between the cell nucleus and the ECM enabling communication between both 
for cell adhesion, migration, growth, differentiation, programmed cell death, modulation of 
cytokine and growth factor activity, and activation of intracellular signaling [75].  The 
influence of the ECM on cellular activities occurs via binding of specific factors to specific 
ECM molecules and binding of ECM molecules to cell surface receptors known as 
integrins, which then influence local release of growth factors or separation of molecules 
(for cell attachment, spreading, and growth) [76, 77].  Beginning as soluble components 
processed within the cells, the ECM is secreted from the cells and is highly regulated by 
and specific to each tissue type and developmental stage [78].  With the goal of imitating 
nature [6], the engineered scaffold must be able to interact with cells in three dimensions 
and facilitate this cell-matrix communication.  In the native tissues, the structural ECM 
proteins (20-500 nm in diameter) are 1 to 2 orders of magnitude smaller than the cell itself, 
which allows the cell to be in direct contact with many ECM fibers, thereby defining its 
three dimensional orientation.  The environmental conditions must be appropriate such that 
signals can be exchanged between cells and between cells and the environment with the 
goal of restoring tissue function.  Thus, the scaffold material, the scaffold fabrication 
technique, and the tissue development methodology must be selected such that in vivo 
chondrocyte-matrix interactions are simulated in vitro. 
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 The three dimensional scaffold provides a structure to which cells can attach, 
migrate, and grow giving the regenerating tissue an initial predefined shape and size.  
These engineered ECMs, or scaffolds, should be designed to conform to a specific set of 
requirements [36, 79-83].  The first requirement is that the material must be biocompatible 
and function without interrupting other physiological processes.  This functionality 
includes an ability to promote normal cell growth and differentiation while maintaining a 
three dimensional orientation/space for the cells.  Secondly, the scaffold should not 
promote or initiate any adverse tissue reaction; this includes any degradation products.  
Once implemented in vitro or in vivo, the material should either be removed via 
degradation and absorption or incorporated via innate remodeling mechanisms, leaving 
only native tissue.  Degradation should be at an appropriate rate such that the newly 
regenerating tissue can support itself and allow effective diffusion of nutrients and wastes.  
The scaffold must possess the mechanical properties necessary to withstand not only the 
forces experienced in situ at the joint (i.e. site of implantation) but also the 
handling/manipulation forces experienced during the implantation procedure.  
Additionally, the scaffold must possess the ability to be retained at the implantation site.  If 
the scaffold has been designed for drug, protein, or cell release, it has to have the proper 
release profile.  In addition, for clinical and commercial success, scaffold production 
should be simple yet versatile enough to produce a wide array of configurations to 
accommodate the size, shape, strength, and other intricacies of the target tissue/organ.  
Finally, surgeons prefer uncomplicated preparation and handling procedures for any 
scaffold.   
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 The native ECM fiber components are one to two orders of magnitude smaller than 
the cell itself, thereby allowing the cell to be in direct contact with many of the fibers 
defining its three-dimensional orientation.  Thus, the determination of suitable pore size, 
total porosity, and ECM fiber size may be crucial in determining the success or failure of a 
tissue-specific tissue-engineering scaffold.  Highly porous scaffolds, such as those with 
porosities greater than 90%, provide sufficient space for cellular infiltration where the cells 
perform actively and exchange nutrients and wastes with the environment [84].   
 
Material Selection: Type II Collagen 
 As described above, there are a number of natural and synthetic materials that have 
been investigated for use in scaffolds for cartilage tissue engineering.  Frenkel and Di 
Cesare have composed a table presenting a summary of in vivo findings of the performance 
of various materials (autologous, natural, and synthetic) (see Appendix A) [36].  Of 
particular interest for this research is type II collagen.  In general it is known that cell-
collagen interactions influence cell growth and differentiation depending on how well the 
cells are able to penetrate the fibrillar collagen ECM [85]. 
 Collagenous scaffolds (of various types of collagen) are of particular interest in 
tissue engineering because these scaffolds mimic the biochemical and ultrastructural 
properties of the native extracellular matrix (ECM) of tissues, which is known to influence 
cell behavior [75, 85].  Since type II collagen is the predominant collagenous component 
of articular cartilage, it is of interest for use in scaffolds for tissue engineering articular 
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cartilage [5, 13, 33].  Nehrer et al. fabricated type I collagen-GAG copolymer sponge 
scaffolds (via freeze drying and dehydrothermal cross-linking) and type II collagen-GAG 
copolymer sponge scaffolds (via reconstituted porcine cartilage and UV irradiation cross-
linking), with an average pore diameter of 85 µm and porosity of 85%; the sponges were 
seeded with autologous chondrocytes, cultured for no longer than 12 hours, and implanted 
into adult canine models for a 15 week study.  The type I and type II collagen structures 
resulted in increased amounts of reparative tissue, both types resulting in comparable 
amounts, but the type II collagen scaffold induced a greater percentage of and more 
uniformly spaced cartilage-like material though it was mostly fibrocartilagenous [33].  
Conclusions were drawn that more time is required to reveal if the transitional tissue will 
eventually convert to hyaline cartilage; also, cell densities and scaffold modifications may 
influence the reparative qualities of the chondral defects.  Previous in vitro studies by 
Nehrer et al. have shown that type II collagen scaffolds have better maintained 
chondrocyte morphology (spherical instead of elongated and flattened) and resulted in 
greater GAG production than have type I collagen scaffolds [86, 87].  Lee et al. used 
similar type II collagen sponges as Nehrer et al. (but with cross-linking in an aqueous 
solution of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-
hydroxysuccinimide) and investigated the implantation (into chondral defects in a canine 
model) of the chondrocyte-seeded sponges following 4 weeks of in vitro static culture.  
Results showed the large production of hyaline-like tissue (51%) in the defects, a fill 
volume of 88%, and little histological evidence of the collagen scaffolds after the 15 week 
implantation period [88].  In a more recent study by Dorotka et al., a collagen membrane 
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(composed of types I and III collagen on the inner, rough surface and type II collagen on 
the outer, porous, cell-seeded surface) was prepared and inserted into osteochondral 
defects already treated with microfracture.  More hyaline tissue (as well as fibrocartilage 
tissue) was observed to grow in these defects over the 4 month study compared to the 
defects treated with microfracture only or microfracture and non-seeded collagen scaffolds; 
from 4 to 12 months, however, the amount of hyaline tissue decreased and the repair tissue 
generally deteriorated [89].  Isolated and purified types I and II collagen have been 
lyophilized and cross-linked by Pieper et al. to prepare scaffolds (pore sizes ranging from 
50 to 100 µm) onto which chondrocytes were seeded and cultured for up to 14 days; results 
showed cells and some clusters of cells with preserved chondrocytic phenotype throughout 
the thickness of the type II collagen scaffolds, a cartilaginous-like layer on the surface of 
the scaffolds (after 14 days of culture), and the presence of newly synthesized GAGs [90].  
Shi et al. created sponge-like scaffolds (with open, interconnected pores between 100 and 
250 µm, and a porosity of 87%) composed of chitosan and type II collagen via a freeze 
drying method followed by cross-linking that were cultured in vitro for 15 days; the 
scaffolds sustained the chondrocytic phenotype and the cells formed some clusters and 
synthesized type II collagen, but the majority of the cells remained on the periphery of the 
scaffolds [91].  Yang et al. compared the redifferentiation of human chondrocytes cultured 
in a pellet and on type II collagen-coated filters.  The cell on the collagen-coated filters 
appeared to have improved type II collagen synthesis compared to those in the pellet 
culture.  Additionally, cells on the filters appeared to be more like native chondrocytes 
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ultrastructurally, and, though cell content decreased in both redifferentiation models, the 
decrease was less on the filters [92]. 
 The scaffold under investigation in this research is composed only of type II 
collagen.  Only one scaffold material was chosen in order to minimize the variables 
associated with scaffold design.  The other interest in using collagen alone is the finding 
that the presence of proteoglycans in the ECM can prevent cell adhesion [13]. 
 As with the other collagenous scaffolds, which have been fabricated in numerous 
ways, particularly as gels and sponges [93-96], freeze-dried solutions of collagen [97, 98], 
and more recently as electrospun fibrous mats [66-68, 99-103], the type II collagen 
scaffolds lack substantial strength upon hydration.  Thus, the structures must be treated or 
fixed in some capacity to render sufficient mechanical integrity to the scaffolds [104].   
 
Fabrication Technique: Electrospinning 
 Conventional polymer processing techniques cannot produce fibers much less than 
10 µm in diameter, which is several orders of magnitude greater than the diameter of 
native ECM fibers, particularly that of collagen.  Thus, scientists in tissue engineering have 
turned to nanotechnology and, specifically, the development of nanofibers, to find 
solutions to the development of tissue engineering scaffolds.  Nanofibers with diameters on 
the order of 20 to 200 nm mimic the geometry of the sub-micron diameter fibers of the 
native articular cartilage ECM, specifically the diameters of native type II collagen fibrils 
[14, 18].  At present, there are only a few processing techniques at the forefront that 
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successfully produce fibers, and subsequent scaffolds, on the nano-scale; Jayaraman et al. 
and Smith and Ma have recently reviewed these techniques [105, 106].  Self-assembly 
involves the spontaneous organization of individual components into an ordered and stable 
structure with non-covalent bonds [107, 108].  Peptide self-assembling systems that form 
nanofibers, with diameters ranging from 30 to 50 nm, for applications as tissue engineering 
scaffolds, have been used by several groups [106-109].  The complexity of the procedure 
and the low productivity of the method limit self-assembly as a large-scale tissue 
engineering option [110].  Ma and Zhang have developed a phase separation technique (a 
thermodynamic separation of a polymer solution into a polymer-rich component and a 
polymer-poor/solvent-rich component) that produces nano-fibrous three-dimensional 
scaffolds.  An advantage to this technique is the control over macroporous networks within 
the fibrous matrices [111, 112].  Additionally, fibers with diameters in the range of 50 to 
500 nm and porosities exceeding 98% are possible [112].  However, this method is limited 
to being effective with only a select number of polymers and is strictly a laboratory scale 
technique [105].  Electrospinning, described previously, is the third technique capable of 
creating polymeric nanofibers, which can be collected in various orientations to create 
unique structures in terms of composition and mechanical properties [50, 62, 64].  
Electrospinning offers further advantages including being cost effective and capable of 
mass production [105].   
 Electrospinning has been chosen as the fabrication technique to create the scaffolds 
for cartilage tissue engineering in this research.  This technique allows control over fiber 
diameter as a function of polymer concentration (linear relationship); thus, diameters 
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approaching those of native ECM fibers can be achieved.  Pores are created in the 
electrospun mats by overlapping fibers.  The scaffolds must possess appropriate porosity to 
allow cell penetration and to provide a place for the cells to be housed [84].  The non-
woven structure of electrospun meshes have porosities greater than 80% [50].  Historically, 
in biomaterials and tissue engineering scaffold design, the most commonly held paradigm 
requires pores larger than 10 microns, and in some cases larger than 100 microns, to allow 
cellular in-growth and vessel formation [113].  Though pore size should be large enough 
for the particular cells to be grown within the scaffold, hypotheses have been made that the 
non-woven structure of the electrospun mats allow migrating cells to maneuver amongst 
the fibers by actually moving the fibers [84, 101] or that fiber degradation occurs during 
cell migration [101], both of which suggest pore size may not be absolutely critical for 
electrospun nanofibrous scaffolds.   
 
Cross-linking: Carbodiimide in Ethanol 
 Cross-linking can be utilized to tailor degradation rate and biomechanical 
characteristics (typically to match those characteristics of the tissue designated for 
regeneration), but it may compromise biocompatibility.  The requirement for tissue 
engineering scaffolds to not elicit any prolonged immune responses has led to research and 
development of fixation techniques that may prove more biocompatible than popular 
chemical cross-linking agents including glutaraldehyde, formaldehyde, and epoxy 
compounds, which have been shown to be cytotoxic because of the reactive moieties that 
45 
are covalently coupled between neighboring collagen fibrils [104, 114-116].  
Glutaraldehyde, in particular, does offer the advantages of being less expensive, reacting 
relatively quickly, cross-linking over varying distances, and reacting with a larger number 
of amino groups present in a protein molecule [114].  It is the most commonly used and 
accepted agent for the cross-linking of biological tissues, but it has also been implicated in 
the development of calcification [114, 117, 118].   
Our laboratory has previously shown that the electrospinning process can facilitate 
the assembly of type I collagen molecules into fibrils that demonstrate the characteristic D-
period banding pattern [99].  Unfortunately, the native intramolecular and intermolecular 
crosslinks (via lysyl oxidase [119]) do not form to a significant degree, if at all, among the 
electrospun fibers.  Herein lies several critical issues involved in the cross-linking of 
electrospun collagen.  Upon hydration in any aqueous solution, the electrospun 
collagenous mats immediately shrink and disintegrate such that the scaffold breaks itself 
apart but does not dissolve.  Thus, cross-linking is a necessity in order to maintain the 
structural integrity of the scaffold.  However, typical protocols for cross-linking 
electrospun collagen have utilized glutaraldehyde, but even then the scaffolds tend to gel 
(unless more severe cross-linking protocols are followed) and lose their nanofibrous 
morphology, which is one of the most important features of the scaffold to begin with.  To 
avoid this, our laboratory has previously electrospun blends of collagen with synthetic 
polymers [120], which has proven successful in initial cell studies, but it is desirable to be 
able to work with collagen-only electrospun scaffolds for cartilage tissue engineering.  
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Thus, a complementary/exogenous cross-linking agent is required if pure collagen 
electrospun scaffolds are to be utilized as tissue engineering scaffolds.   
Choice of cross-linking agent requires knowledge of the reactive group(s) present, 
typically an amino acid side chain, and appropriate ambient conditions (such as pH, 
temperature, solvent, etc.) that do not negatively affect the protein [104].  In choosing a 
cross-linking agent for collagen, heterobifunctional agents, which contain two different 
reactive groups that are able to directly link two different amino acid side chains [121], are 
of interest in maximizing the extent of cross-linking.  The great interest in 
heterobifunctional carbodiimides, in particular 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC), is that these are zero-length 
cross-linking agents, i.e. the agent itself is not incorporated into the macromolecule.  The 
protonated carbodiimide reacts with the carboxylic functional groups of aspartic and 
glutamic amino acids and forms the intermediate O-isoacylurea, which then undergoes 
nucleophilic attack by the amine functional groups of lysine and hydroxylysine amino 
acids on adjacent collagen fibrils.  The crosslink, an iso-peptide bond (that mimics the 
natural peptide bonds in proteins), is formed thereby bridging neighboring polypeptide 
chains, and a urea derivative is released that can be removed via rinsing [116, 122].  By 
modifying the ratio of EDC to collagen, the extent of cross-linking can be controlled [104].  
EDC has been used to cross-link reconstituted collagen fibrils, i.e. collagen molecules 
removed from tissues via acid or enzyme extraction that spontaneously form fibrils [90, 
123, 124], insoluble collagen, and collagen fibers from intact tissues [104, 122, 125-127].  
EDC is suited for use with type II collagen from bovine cartilage because each of the three 
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α1(II) chains that constitute the triple helical structure consists of 15 lysine, 23 
hydroxylysine, 43 aspartic acid, and 87 glutamic acid residues per thousand residues per 
chain [128]. 
A method of cross-linking electrospun type II collagen (highly purified) scaffolds 
utilizing carbodiimide in an ethanol solution has been developed to effectively cross-link 
the collagen by creating iso-peptide interfibrillar bonds while minimizing the shrinkage of 
the collagenous mats [129].  The use of EDC in a non-aqueous solution will cross-link 
electrospun type II collagen fibrous matrices in a comparable manner to typical 
glutaraldehyde fixation protocols.  Ethanol has been used previously with collagenous 
materials without report of deleterious effects such as denaturation.  Additionally, ethanol 
has been used with glutaraldehyde in the treatment of aortic cusps to minimize the effects 
of calcification [130].  Pieper et al. have investigated the cross-linking of lyophilized 
collagen matrices (extracted from bovine achilles tendon) in the presence of 40% v/v 
ethanol to preserve the porosity of the collagen matrix; these matrices resulted in 
comparable tensile strengths to matrices cross-linked in aqueous EDC alone [90, 123].  
Buttafoco et al. utilized EDC and N-hydroxysuccinimide (NHS) in a 2-morpho-linoethane 
sulfonic acid (MES) buffer in 70% v/v ethanol/water for cross-linking electrospun type I 
collagen (electrospun from hydrochloric acid with poly(ethylene oxide) and sodium 
chloride added).   
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Tissue Development Methodology 
 Most often the tissue engineering of articular cartilage involves the use of a 
scaffold onto which articular chondrocytes or their precursor cells are seeded in order to 
grow a three-dimensional tissue in vitro that can later be implanted into the joint defect 
[35, 55].  The goal is to achieve in vitro chondrogenesis that matches native in vivo 
chondrogenesis and mimics the mechanical and biochemical properties of the native tissue.  
This in vitro chondrogenesis is dependent upon cell type, initial cell density, scaffold 
characteristics, and culture conditions.  For the research presented here, scaffolds created 
via the electrospinning fabrication technique and then seeded with chondrocytes were 
maintained in a bioreactor growth environment to investigate a novel approach to articular 
cartilage tissue engineering (Figure 14).  The specific aim of this study was to achieve 
tissue that likened the mechanical and biochemical properties of the middle zone of 
articular cartilage since the scaffolds consist of randomly arranged fibers and would not be 
degraded by the end of the 6 week duration.   
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Figure 14.  Schematic of the design approach used in this research. 
 
 
Chondrocytes 
 In vitro chondrogenesis can be achieved via the seeding of the designed scaffolds 
with cells capable of synthesizing articular cartilage ECM; these cells are namely 
chondrocytes or their precursor cells (chondroprogenitor cells derived from marrow, 
periosteum, or perichondrium).  Chondrocytes offer the advantage of already being capable 
of producing type II collagen and GAGs since they are already of the correct phenotype.  
Disadvantages include being limited in availability and resulting in donor-site morbidity 
[45].  Expansion in culture is necessary to obtain sufficient numbers of chondrocytes for 
seeding, but the main problem is dedifferentiation into a fibroblastic phenotype during 
culture.  This dedifferentiation results in a change in the synthesis of type II collagen to 
types I and III [43].  Thus, chondroprogenitor cells, and in particular marrow-derived 
mesenchymal stem cells have been investigated as an alternative [45, 58]. 
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 Chondrocytes have been chosen in this research to be seeded onto the scaffolds 
since these cells are responsible for producing the matrix components (type II collagen and 
aggrecan) that give the cartilage strength and flexibility.  It has been shown that suspension 
of passaged chondrocytes within a three-dimensional matrix (such as agarose gels and 
alginate beads) and special culturing techniques (such as suspension cultures, high-density 
cultures, and co-cultures with primary chondrocytes) can induce redifferentiation from the 
fibroblastic phenotype back into the chondrocytic phenotype by restoring the spherical 
shape of the cells [20, 44, 46, 131, 132].  This research will investigate the differentiation 
status of the chondrocytes on the electrospun type II collagen scaffolds.  It still remains to 
be shown whether chondrocytes that have been passaged several times in monolayer 
culture can produce tissue of favorable cartilage quality and quantity [46].   
 
Bioreactor 
 Ideally, since this research is addressing the tissue engineering of the middle zone 
of articular cartilage, the desired tissue outcome is a uniform spatial distribution of 
chondrocytes within the three-dimensional scaffold structure.  Static culture vessels can 
result in poor cellular infiltration into the thickness of the scaffold due to poor mass 
transport of nutrients and wastes; thus, only a layer of cells on one side of the scaffold may 
develop.  Mixed/spinner flasks do provide a well-mixed environment around the cells, but 
may result in the formation of a fibrous capsule around the scaffold structure because of 
the turbulent flow and associated shear stress that is too high [57].  On the other hand, 
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bioreactors are designed to maintain cells and tissue in continuous free fall (simulated 
microgravity), providing a buoyant, low shear environment (for mechanical stimulation) 
and high mass transfer of nutrients.  The buoyant environment of these devices fosters cell-
cell and cell-matrix contacts and the formation of large cell masses.  The in vitro culture 
conditions within the bioreactor can be controlled such that the chondrocytes are able to 
proliferate within the scaffold while degrading and replacing it with new extracellular 
matrix components.  One negative of the bioreactor environment is that cells within the 
scaffold align in the direction of the shear forces; this is not ideal since the different zones 
of articular cartilage have cells with different alignments relative to the surface [57].  Other 
drawbacks to the rotating wall vessel bioreactor include non-uniform growth of tissue and 
collision of the scaffolds with the vessel wall resulting in cell damage and disturbances 
with cell attachment and matrix deposition [57].  Despite the disadvantages, the bioreactor 
growth environment is best for the desired tissue-engineered structure proposed in this 
particular study [60, 133].  The bioreactor used in this research is the Slow Turning Lateral 
Vessel (STLV) on the Rotary Cell Culture System (RCCS) (Synthecon™, Inc.), which is a 
rotating wall vessel in which the scaffolds flow between two concentric cylinders, the inner 
of which is a silicone gas exchange membrane. 
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Methods 
 
Collagen Preparation 
 Type II collagen was extracted from articular cartilage removed from all joints of 
fetal calf legs [134].  For a detailed checklist of extraction and purification steps, see 
Appendix B.  Unless otherwise stated, all procedures were performed at 4ºC.  To a slurry 
of homogenized cartilage, guanidine (2.5 M final concentration) and Tris (0.025 M final 
concentration), pH 7.4, were added and stirred overnight.  Following four rinses with cold 
deionized water, the cartilaginous tissue was suspended in 0.5 M acetic acid, pH 2.8.  
Pepsin (2x, Sigma-Aldrich Chemical Co.) was added to the mixture at 1 g per 1 L solution 
and incubated overnight.  The viscous supernatant containing solubilized collagen was 
adjusted to pH 7.4; sodium chloride was added to a final concentration of 5 M while 
stirring slowly.  The solution was incubated overnight at room temperature, after which the 
collagen precipitate was dissolved in 0.05 M Tris/0.2 M sodium chloride, pH 7.4.  This 
solution was dialyzed (Spectrum Spectra/Por 4 RC Dialysis Membrane Tubing 12000-
14000 MWCO, Fisher Scientific International Inc.) against a buffer solution containing 
0.05 M Tris/0.2 M sodium chloride buffer, pH 7.4, and allowed to equilibrate overnight; 
this was repeated two additional times.  Anion exchange microgranular diethylaminoethyl 
cellulose separation media, DE-52 (Whatman, Fisher Scientific International Inc.), was 
added to the collagen solution (at 100 g per liter of solution) and incubated overnight.  To 
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the supernatant, sodium chloride (0.8 M final concentration) and acetic acid (0.1 M final 
concentration) were added and stirred overnight.  The precipitated collagen was dissolved 
in 0.1 M acetic acid, and the resulting solution was dialyzed against a solution containing 
0.01 M acetic acid overnight with stirring; this was repeated six additional times.  Finally, 
the purified collagen solution was frozen and lyophilized until dry product was obtained.   
 
Collagen Purity and Apparent Molecular Weight 
Isolated (lyophilized) and electrospun type II collagen were dissolved in 50 mM 
acetic acid solution at a concentration of 4 mg/mL.  These solutions were analyzed by 
SDS-PAGE gel electrophoresis under denaturing conditions for purity and apparent 
molecular weight determination.  Briefly, 40 µg of purified or electrospun collagen were 
prepared by the addition of 1X SDS sample buffer and boiled for 3 minutes.  The samples 
were resolved using an 8-16% gradient SDS-PAGE gel (Criterion precast gel, BioRad) 
and visualized using GelCode blue stain reagent (Pierce). 
 
Electrospinning 
The lyophilized collagen was dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol (HFP, 
TCI America, Portland, OR) at concentrations of 60, 80, 100, and 120 mg/mL at room 
temperature; this concentration range was previously determined as the electrospinning 
range for type II collagen [135].  The collagen solution was electrospun to create 
randomly-oriented, non-woven, fibrous mats.  Figure 13 illustrates the electrospinning 
process.  The apparatus used includes a syringe pump (KD Scientific), a high voltage 
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power supply (Spellman CZE1000R, Spellman High Voltage Electronics Corp.), a syringe 
(Becton Dickinson, plastic) as the reservoir for the polymer solution to which is attached 
an 18-gauge blunt-end needle, and a 303 stainless steel mandrel (7.6 cm length x 2.5 cm 
width x 1.6 cm thickness) as the collection target.  All electrospinning parameters were 
kept constant, including applied voltage (22 kV), distance between the needle and 
grounded mandrel (12.7 cm), solution dispensing rate (2 mL/hr), translational speed (2 
cm/s over a 7.3 cm distance), and rotational speed (500 rpm for random fiber orientation).  
There was no grounded plate behind the mandrel.  For each mat, 5 mL of solution was 
electrospun.   
 
Cross-linking of Collagen Scaffolds 
 The carbodiimide cross-linking solution was prepared by dissolving the solid cross-
linking agent, N-(3-Dimethylaminopropyl)-N’-ethyl-carbodiimide hydrochloride (EDC, 
Sigma-Aldrich Chemical Co.), in pure ethanol (Fisher Scientific Inc.) to the desired 
concentration of 20 mM.  Electrospun mats of each of the 4 concentrations (with 
approximate dimensions 6 cm length x 2 cm width) were submerged in 20 mL of the EDC 
solution and incubated with shaking for 18 hours.  After cross-linking, the mats were 
placed in 20 mL of 0.1 M sodium phosphate for 2 hours to hydrolyze any unreacted O-
isoacylurea intermediates.  Finally, all samples were rinsed and soaked in sterile phosphate 
buffered saline (PBS) for at least 2 hours.   
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Fiber Diameter and Pore Size Measurement of Dry Scaffolds 
Fiber and pore morphologies of the dry (uncross-linked) electrospun mats were 
viewed with scanning electron microscopy (SEM) using a JEOL JSM-820 JE electron 
microscope (Japanese Electron Optical Ltd., Japan).  A micrograph was taken and digitized 
with a Hewlett-Packard Scanjet 5550c flatbed scanner and then examined with UTHSCSA 
ImageTool 3.0 imaging software (NIH shareware) to measure fiber diameter and pore size.  
Mean and standard deviation were determined from 60 fiber diameter measurements and 
40 pore area measurements; calibration for each micrograph was made with the scale bar 
on the micrograph.   
 
Fiber Diameter, and Pore Size Measurement of Hydrated Scaffolds 
Environmental scanning electron microscopy (ESEM) was used to take images of 
the 60 mg/mL cross-linked mat in the hydrated state.  The microscope used was a Philips 
XL30 ESEM TMP (FEI Company, Hillsboro, OR) purchased under the NSF award # DBI-
0098534 at the Duke University, Department of Biology, Scanning Electron Microscopy 
Lab.  For improved image quality, the hydrated sample was blotted slightly to remove 
excess water such that the sample could be fixed to the sample holder.  The grayscale of 
the digital images taken with the ESEM was inverted to allow for improved viewing of the 
topography of the mat surface.  Mean and standard deviation were determined from 60 
fiber diameter measurements and 40 pore area measurements; calibration for the 
measurement was made with the scale bar on the digital image.  There have been problems 
utilizing the ESEM in the Department of Neurobiology and Anatomy Microscopy Facility 
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at Virginia Commonwealth University; thus, only the 60 mg/mL scaffold will have 
morphology data in the dry and hydrated states for comparison. 
 
Porosity Measurement 
 Porosity, expressed as the percentage void to total volume, was determined by the 
following equation:  
100
ρ
ρ-1 Porosity 
0
×


=  
where ρ is the calculated density of the scaffold determined by dividing the mass 
(measured in the dry state) by the overall volume (measured in the hydrated state) of the 
mat and ρ0 is the density of collagen (1.41 g/cm3).  Three samples were used to determine 
the porosity of each scaffold of each concentration.   
 
Permeability Measurement and Fiber Diameter and Pore Size Determination of 
Hydrated Scaffolds 
 
 The permeability of three punches (1 cm diameter) from each cross-linked, 
electrospun mat of each concentration was measured in the hydrated state (soaked in PBS 
for at least 2 hours at room temperature beyond cross-linking protocol).  A meter 
developed by Scott Sell based on Ogston’s theory of flow through systems of long thin 
rods was employed for permeability measurement, and the fluid utilized for the testing was 
PBS to mimic the physiologic ionic strength [136, 137].  Permeability, represented as the 
Darcy constant (τ), is calculated using the following equation: 
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h  ηQτ =  
where Q is the volume that flows through in time t (mL/sec), η is the viscosity of the fluid, 
h is the thickness of the scaffold, F is the cross-sectional area of the scaffold, and p is the 
applied pressure (proportional to the height of the meter).  The average fiber diameter (d) 
can then be calculated from the Darcy constant as follows:  
Φ τk d =  
where k is a constant determined to be equal to 10 [137], and Φ is the volume fraction of 
the collagen in the scaffold.  The average pore area (using the assumption of a circular pore 
shape) can be determined based on the equation for the average pore radius (R) as follows:  
2
1-τ
0.5093  R = . 
 
Tensile Testing (Stress-Strain Relationship) of Hydrated Scaffolds 
Mechanical properties of the cross-linked mats were measured in the hydrated state 
(soaked in PBS for approximately 2 hours at room temperature) to show behavior under 
approximate physiological conditions.  Uniaxial tensile testing of the mats on a MTS 
Bionix 200 Mechanical Testing System (MTS Systems Corp., Eden Prairie, MN), 
incorporating a 50N load cell with an extension rate of 10.0 mm/minute to failure, was 
performed on four “dog-bone” shaped samples (2.67 mm wide at their narrowest width and 
a gage length of 7.49 mm) punched from each mat of each concentration.  The data 
acquisition rate was 20 Hz.  The mechanical properties recorded include tangential 
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modulus, peak stress, and strain at failure, which were calculated by the MTS software 
TestWorks 4.0. 
 
Scaffold Preparation and Disinfection 
 From each cross-linked, electrospun mat of each concentration, scaffold discs were 
punched using a 1.0 cm biopsy punch.  The scaffold discs were placed in petri dishes, 
covered with 100% ethanol, and allowed to soak for 10 minutes.  The ethanol was removed 
with a pipette and the scaffold discs were rinsed with sterile PBS four times (10 minutes 
per rinse).  The scaffold discs were stored in sterile PBS until cell-seeding.   
 
General Culture of Chondrocytes 
 Clonetics normal human articular chondrocytes from the knee (NHAC-kn) were 
purchased from Cambrex Corporation.  The cells were cultured in tissue culture plastic 
flasks in monolayer (until sufficient numbers were attained) under standard culture 
conditions: 37ºC at 5% CO2 and constant humidity in an incubator.  Sterile technique was 
followed and all work was performed in a laminar flow workstation.  While in monolayer, 
the growth media used was Dulbecco’s Modified Eagle Medium with Nutrient Mixture F-
12 (Invitrogen Corporation) supplemented with 10% fetal bovine serum and 1% penicillin-
streptomyocin (10,000 Units/mL each).  The cells were used at passage three.   
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Initial Cell-Seeding Investigation 
 An initial cell-seeding investigation was performed to determine which method 
would result in attachment of the most cells with the most uniform distribution.  Five 
scaffold discs total, 1.0 cm in diameter, were punched from a 60 mg/mL cross-linked, 
electrospun mat.  Three discs were placed in a 48-well plate for static culture.  0.25 mL of 
the media and cell mixture was added to two of the discs at a cell density of 5x105 
cells/mL media, and 0.25 mL of media alone was added to the third disc (the control with 
no cells); after about 2 hours, another 0.25 mL of media was added on top of all three 
discs.  A media height of approximately 2 mm was maintained above the scaffold surface, 
and more media was added if evaporation occurred.  Two scaffold discs were placed in a 
55 mL bioreactor (Slow Turning Lateral Vessel (STLV) on the Rotary Cell Culture System 
(RCCS) (Synthecon™, Inc.)) for dynamic culture with an initial cell density of 5x105 
cells/mL media; rotation was started at 15 rpm and increased to 20 rpm after one day.  
Both cultures were maintained (under standard culture conditions) for three days so that 
the growth media did not have to be replaced.  The media used in this initial investigation 
was the same as that described for the general culture of chondrocytes.  The cell density 
used was determined based on previous bioreactor studies by Vunjak-Novakovic et al. [60, 
138].  After three days of culture, all scaffolds were removed, placed in 10% formalin, and 
processed for histology (Hematoxylin and Eosin staining).   
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Scaffold Seeding and Tissue Culture in Bioreactors 
 Clonetics standard chondrocyte growth media (Cambrex Corporation) was 
prepared by adding the entire amount of each supplement in the BulletKit (CGM 
SingleQuots CC-4409) to the basal medium (CC-3217); thus, supplementation included 
5% fetal bovine serum, 0.1% gentamicin sulfate amphotericin-B, 0.2% bovine insulin, 
0.5% r-human fibroblast growth factor-B, 0.1% transferrin, and 0.2% insulin-like growth 
factor-1.  Twelve scaffold discs, 1.0 cm in diameter, were punched from each cross-linked, 
electrospun mat of each concentration, for a total of 48 scaffold discs, and soaked in media 
before cell-seeding.  Four 55 mL bioreactor chambers (Slow Turning Lateral Vessel 
(STLV) on the Rotary Cell Culture System (RCCS) (Synthecon™, Inc.)) were conditioned 
prior to use (i.e. filled with media, bubbles removed, attached to RCCS in incubator, turned 
on to rotate, and left about 24 hours in incubator to check for leaks).  Nine scaffolds of 
each concentration were transferred under sterile conditions to one bioreactor chamber 
(Figure 15) and 3 scaffolds of each concentration were placed in media (without cells) to 
serve as controls; thus, there were 4 bioreactor chambers each with a different 
concentration of electrospun type II collagen (Figure 15).  Chondrocytes were resuspended 
in media (to a density of 4.3x105 cells/mL media) and added to each bioreactor chamber 
such that the concentration of cells was 2.6x106 cells/scaffold.  For improved seeding 
efficiency and uniformity, the cells were seeded on the scaffolds in this dynamic manner 
within the bioreactor (as opposed to statically).  Three full days were allowed for cell 
seeding before the media was changed.  The media was completely changed about every 
third day.  Three scaffolds of each concentration were removed after 2, 4, and 6 week 
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culture periods (Figure 15).  All culturing was performed under standard culture 
conditions: 37ºC at 5% CO2 and constant humidity in the incubator.  The rates of rotation 
necessary to suspend the scaffold discs in continuous free fall were determined 
experimentally.  In general, it was found that a rate of 22 rpm was sufficient to maintain 
the scaffold discs in free fall during tissue development; by the sixth week, the rate was 
increased to 25 rpm.   
 
 
Figure 15.  Photographs of the (A) four STLVs on the RCCS in the incubator, (B) a single 
STLV bioreactor chamber with a scaffold disc rotating within, and (C) the scaffolds 
removed from the chambers. 
 
 
Thickness Measurement of Cultured Tissue 
 After removal from the bioreactor at the 2, 4, and 6 week culture periods, the 
thicknesses of the scaffold discs were measured with a dial caliper.  There were three 
measurements for each concentration at each time period.  These measurements were 
A B 
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compared to the thickness measurements of the scaffolds prior to cell seeding.  All scaffold 
discs were measured in the hydrated state without compression such that fluid was not 
forced out/removed from the discs. 
 
Stress Relaxation Testing of Cultured Tissue 
 An indenter (cylindrical, 2 mm diameter, plane-ended, stainless steel) was attached 
to the MTS Bionix 200 Mechanical Testing System (MTS Systems Corp., Eden Prairie, 
MN) incorporating a 50N load cell as shown in Figure 16.  Indentation was performed in 
the center of each scaffold disc, perpendicular to the scaffold surface.  The discs were 
placed in a glass petri dish and kept hydrated with growth media.  Three discs for each 
concentration were tested at each time period.  The following parameters were used: test 
speed of 0.5 mm/min, data acquisition rate of 10 Hz, hold time of 200 s, and a preload of 
0.015 N for the first run only (to ensure contact); the temperature in the room fluctuated 
between 75 and 81ºF.  The indenter was lowered to contact the scaffold, and five 
successive ramp-and-hold displacements were applied to achieve 5, 10, 15, 20, and 25% 
strains.  After each ramp-and-hold displacement, stress relaxation was achieved within 200 
seconds; the equilibrium stress was calculated with the measured equilibrium load 
(recorded by the MTS software TestWorks 4.0).  An equilibrium stress-strain curve was 
plotted and the slope of the most linear portion was taken to be the equilibrium stiffness (or 
indentation stiffness) of the cultured tissue.  This method has been used by others 
investigating the mechanical properties of cartilage [88, 139].   
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Figure 16.  Photographs of the stress relaxation testing with (A) the Mechanical Testing 
System (MTS) and (B) the indenter. 
 
 
Cell Density Analysis of Cultured Tissue 
 The cell density in each scaffold construct per weight (i.e. wet mass) was 
determined based on DNA concentration via fluorometric analysis with Hoechst 33258 dye 
[140].  The following chemical preparations were made.  Papain was dissolved in sterile 
PBS at 125 µg/mL, pH 6.0, with 5 mM cysteine·HCl and 5 mM Na2EDTA.  A stock 
solution of Hoechst 33258 dye was made at 1 mg/mL in distilled water and stored in a foil-
wrapped container at 4ºC; the working solution of dye was prepared immediately before 
use by diluting the working solution to 0.2 µg/mL in 10 mM Tris, 1 mM Na2EDTA, 0.1 
mM NaCl, pH 7.4, and it was put in an amber bottle.  Calf thymus DNA was made at 100 
µg/mL in PBS, and dilutions of 0 to 100 µg DNA/mL PBS were prepared for the standard 
curve.  From each of the 3 scaffold discs of each concentration, a 3 mm biopsy punch was 
taken (see Figure 17).  Each biopsy punch was rinsed in PBS, weighed wet with an 
A B 
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analytical balance, placed in a cryovial, and digested in 1 mL papain solution for 13.5 hr at 
60ºC.  Additionally, cultured chondrocytes (in monolayer) were passaged, counted, 
prepared as dilutions, pelleted, and treated the same as the biopsy punches.  To 100 µL of 
each papain-digested sample, 1 mL of dye solution was added with gentle shaking.  300 µL 
of each of these solutions were placed into wells of a 96-well plate.  The Hoechst dye 
working solution was used as a blank.  The FLUOstar fluorometer (BMG Lab 
Technologies) with FLUOstar Galaxy software was used in the fluorometric assay in 
which the excitation wavelength was 320 nm (ideally would be 365 nm) and the emission 
wavelength was 460 nm (ideally would be 458 nm).  Eight cycles were run and recorded.  
The DNA content per chondrocyte has previously been shown to be 7.7 pg per cell [140].   
 
 
Figure 17.  Photograph of the 3 mm biopsy punches taken from each scaffold disc for cell 
density, GAG, type I collagen and type II collagen, and histological analyses. 
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Glycosaminoglycan (GAG) Analysis of Cultured Tissue 
 The GAG concentration in each scaffold construct per weight (i.e. wet mass) was 
determined via use of dimethylmethylene blue dye [86, 141, 142].  The following chemical 
preparations were made.  16 mg of 1,9-dimethylmethylene blue was dissolved in 1 L of 
water containing 3.04 g glycine, 2.37 g NaCl, and 95 mL 0.1 M HCl, solution pH 3.0 with 
an absorbance of 0.31 at 525 nm; the solution was stored in a brown bottle at room 
temperature.  Papain was dissolved at 50 µg/mL in 0.1 M sodium phosphate, 5 mM 
cysteine·HCl, and 5 mM Na2EDTA, pH 6.0.  Bovine chondroitin sulfate was made at 100 
µg/mL in the buffer solution above, and dilutions of 0 to 100 µg/mL were prepared for the 
standard curve.  From each of the 3 scaffold discs of each concentration, a 3 mm biopsy 
punch was taken (see Figure 17).  Each biopsy punch was rinsed in PBS, weighed wet with 
an analytical balance, placed in a cryovial, and digested in 1 mL papain solution for 2 hr at 
60ºC.  To a 33 µL aliquot of each papain-digested solution and the standards placed into 
wells of a 96-well plate, 300 µL of 1,9-dimethylmethylene blue dye solution was added.  
The buffer solution was used as the blank.  The absorbance was measured at 525 nm in the 
SPECTRAmax PLUS384 microplate spectrophotometer (Molecular Devices).  Pipetting, 
mixing, and measurement were performed as quickly as possible due to the instability of 
the dye color.   
 
Type II Collagen Synthesis in Cultured Tissue 
 From each of the 3 scaffold discs of each concentration, a 3 mm biopsy punch was 
taken (see Figure 17).  Each biopsy punch was rinsed in cold distilled water, weighed wet 
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with an analytical balance, placed in a cryovial, and incubated in 1 mL of cold distilled 
water at 4ºC overnight.  The swollen tissue was resuspended in 0.5 mL of 3 M guanidine 
hydrochloride/0.05 M Tris-HCl buffer, pH 7.5, and mixed on a rocker at 4ºC overnight.  
The tissue was centrifuged for 3 min at 10,000 rpm, and the precipitate was washed with 
cold distilled water three times and then resuspended in 0.8 mL of 0.05 M acetic acid 
containing 0.5 M NaCl, pH 2.9-3.0 (adjusted with formic acid).  0.1 mL of pepsin solution 
(10 mg/mL dissolved in 0.05 M acetic acid) was added to each sample and mixed at 4ºC 
for 48 hours.  0.1 mL of 10X TBS (1.0 M Tris/2.0 M NaCl/50 mM CaCl2) was then added 
and the pH was adjusted to 8.0 with 1 N NaOH.  Finally, 0.1 mL of pancreatic elastase (1 
mg/mL dissolved in 1X TBS, pH 7.8-8.0) was added and mixed at 4ºC overnight on a 
rocker.  The samples were centrifuged at 10,000 rpm for 5 min and the supernatants were 
collected (the tissues appeared completely solubilized).  Until tested with the type II 
collagen ELISA, the samples were kept frozen at -20ºC. 
 The Native Type II Collagen Detection Kit by Chondrex, Inc. (Redmond, WA) was 
used to perform an ELISA on the digested tissue samples in order to quantify the amount 
of type II collagen in the cultured tissue per weight (i.e. wet mass).  Briefly, each of the 
following chemicals was consecutively placed in wells of a 96-well plate provided in the 
kit, allowed to incubate, and then rinsed away with the wash buffer provided in the kit: a 
capture antibody (100 µL per well, incubated at 4 ºC overnight), the samples and standards 
(dilutions were prepared from the type II collagen standard provided in the kit) (100 µL per 
well, incubated at room temperature for 2 hours), a detection antibody (100 µL per well, 
incubated at room temperature for 2 hours), and Streptavidin Peroxidase (100 µL per well, 
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incubated at room temperature for 1 hours).  Tablets of urea H2O2 and o-phenylenediamine 
(OPD) chromagen were dissolved in water and added to each well (100 µL per well, 
incubated at room temperature for 30 min); the reaction was stopped with 2N sulfuric acid 
(50 µL per well).  Optical density values were measured with the SPECTRAmax PLUS384 
microplate spectrophotometer (Molecular Devices) at 490 nm.   
 
Type II/Type I Collagen Ratio in Cultured Tissue 
 From each of the 3 scaffold discs of each concentration, a 3 mm biopsy punch was 
taken (see Figure 17).  Each biopsy punch was rinsed in cold distilled water, weighed wet 
with an analytical balance, placed in a cryovial, and incubated in 1 mL of cold distilled 
water at 4ºC overnight.  These punches were processed exactly the same as described 
above for the type II collagen analysis.  The samples were kept frozen at -20 ºC until tested 
with the type I collagen ELISA. 
 The Human Type I Collagen Detection Kit by Chondrex, Inc. (Redmond, WA) was 
used to perform an ELISA on the digested tissue samples in order to quantify the amount 
of type I collagen in the cultured tissue per weight (i.e. wet mass).  The procedure for this 
kit is exactly the same as described above for the type II collagen analysis except that the 
capture and detection antibodies are specific for type I collagen.  After quantifying the 
amounts of type I collagen in each sample, the ratio of type II to type I collagen can be 
calculated for each electrospun type II collagen concentration. 
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Histological Evaluation of Cultured Tissue 
 From each of the 3 scaffold discs of each concentration, two 3 mm biopsy punches 
were taken (see Figure 17).  All of these punches were placed in 10% formalin and 
processed for histology; one of the two punches from each scaffold disc was stained with 
Hematoxylin and Eosin (H&E) and the other with Masson’s Trichrome.  For each punch, a 
slide with nine cross-sectional slices was prepared for viewing with a light microscope.  
Cellular distribution within the scaffolds and cellular morphology was assessed 
qualitatively.   
 
Statistical Analysis 
 Statistical analysis was performed on all data recorded in the experiments described 
above.  Unless otherwise stated, all statistical analysis was based on a one-way analysis of 
variance and a Tukey-Kramer pair-wise multiple comparison procedure (with an a priori 
significance level of α = 0.05) performed with the JMPIN 4.0.3 statistical software 
package (SAS Institute, Inc.).  Graphs of the results were constructed with Microsoft Excel 
2000.  The goals of the statistical analysis were as follows: to determine if the electrospun 
collagen concentration had significantly different influences on the fiber diameter, pore 
size, permeability, and mechanical properties of the mats, and to determine if the 
electrospun collagen concentration (i.e. resulting fiber diameter and pore size) and/or the 
culture time had any effects on the mechanical properties of and the cellular responses 
within the cultured tissue.   
 
 69 
 
 
Results 
 
 The results of the following are given in this section: the purity of the type II collagen, 
the physical characterization of the scaffolds, the biomechanical testing of the electrospun 
mats and scaffolds (uniaxial tensile and stress relaxation), the biochemical characterization of 
the scaffolds, and the histological analysis of the scaffolds.  Additionally, comments are made 
regarding the results of the statistical analysis; data from the statistical analysis is given in 
Appendix C.   
 
Collagen Purity 
 Type II collagen has successively been extracted and purified from fetal calf legs for 
use in this research.  Figure 18 gives the results of the SDS-PAGE; the apparent molecular 
weight, determined to be 150 kDa, and the purity of the collagen samples are consistent with 
the type II collagen standard supplied by the University of Tennessee, RDRCC Collagen Core 
Center [134].  The stained band for the electrospun sample is a result of a more dilute solution 
loaded into the gel.   
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Figure 18.  SDS-PAGE analysis of the purified collagen from two different extractions (Ext 1 
and Ext 2) and of electrospun collagen (Espun) was conducted to determine the apparent 
molecular weight and purity.  The 150 kDa bands of Ext 1, Ext 2, and Espun are consistent 
with the molecular weight of the type II collagen standard (C II) and appear to be 
homogeneous. 
 
 
Physical Characterization of Dry and Hydrated Scaffolds 
 Figure 19 gives SEMs of the dry electrospun mats of type II collagen prior to cross-
linking, and Figure 20 shows the ESEM of the hydrated 60 mg/mL type II collagen cross-
linked, electrospun mat.  The handling characteristics of the electrospun mats, immediately 
removed from the mandrel, are such that the mat can be gently manipulated by hand without 
permanent deformation to the structure.  Table 2 gives the fiber diameter, pore size, porosity, 
and permeability measurements of the dry (uncross-linked) and hydrated (cross-linked) 
scaffolds before any culturing was performed.  To better illustrate the relationship between 
electrospinning solution concentration and fiber diameter and pore area, Figure 21 gives the 
trend lines produced using the data.  A linear relationship does exist between concentration 
and fiber diameter measured using the scanning electron micrographs, but no other linear 
relationships exist, particularly not between concentration and pore area.  At P<0.0001, there 
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is a statistically significant difference between all of the diameter means (for each 
concentration) measured from the scanning electron micrographs, and there is a significant 
difference between the 60 mg/mL concentration mean fiber diameter measurements for dry 
and hydrated mats measured with SEM and ESEM, respectively.  For the diameter 
calculations made using the permeability data, the following significant differences were 
determined: the 60 mg/mL concentration is different from the 100 mg/mL and the 120 mg/mL 
concentrations, and the 80 mg/mL concentration is different from the 100 mg/mL and the 120 
mg/mL concentrations.  The only significant difference calculated within the pore area 
measurements made with SEM is between the mean pore areas for the 60 mg/mL and the 100 
mg/mL concentrations; there is no significant difference between the 60 mg/mL concentration 
mean pore area measurements for dry and hydrated mats measured with SEM and ESEM, 
respectively.  The mean pore area values determined from the permeability data are all 
statistically significantly different from one another except for the 60 mg/mL and 80 mg/mL 
concentrations which are not significantly different from each other.  The porosity of all of the 
electrospun mats falls between 84 and 90%; none of the porosity means for the different 
concentrations are statistically different from one another.  There is a trend toward increasing 
permeability as concentration increases with the exception of the 120 mg/mL concentration.  
Additionally, the mean permeability values are all statistically significantly different from one 
another except for the 60 mg/mL and 80 mg/mL concentrations which are not significantly 
different from each other.   
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Figure 19.  Scanning electron micrographs of dry (uncross-linked) type II collagen 
electrospun mats at (A) 60 mg/mL, (B) 80 mg/mL, (C) 100 mg/mL, and (D) 120 mg/mL 
(scale bar is 1 µm). 
 
 
Figure 20.  Environmental scanning electron micrograph of hydrated (cross-linked) type II 
collagen electrospun mat at 60 mg/mL (scale bar is 10 µm). 
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Table 2.  Fiber diameter, pore size, porosity, and permeability measurements for the type II 
collagen electrospun mats; results are given as mean ± standard deviation. 
Electrospun Concentration 
60 80 100 120 Measurement Measurement Technique mg/mL mg/mL mg/mL mg/mL 
SEM (dry) 107 ± 38 184 ± 74 309 ± 12 446 ± 232 
ESEM (hydrated) 232 ± 57 — — — Fiber Diameter (nm) 
Permeability Meter 289 ± 94 318 ± 41 618 ± 79 592 ± 45 
SEM (dry) 1.76 ± 1.76 2.12 ± 1.73 3.17 ± 2.44 2.92 ± 2.28 
ESEM (hydrated) 1.68 ± 1.55 — — — Pore Size (µm2) 
Permeability Meter 0.00055 ± 0.00012 
0.00080 ± 
0.00030 
0.00282 ± 
0.00029 
0.00181 ± 
0.00034 
Porosity (%) Dry mass/wet volume 87.3 ± 6.4 89.1 ± 2.1 88.8 ± 2.6 84.1 ± 0.5 
(x10-4 D) 6.82 ± 1.45 9.91 ± 3.73 35.0 ± 3.6 22.5 ± 4.2 Permeability (x10-13 m4/Ns) Permeability Meter 7.56 ± 1.61 11.0 ± 4.1 38.8 ± 4.0 24.9 ± 4.6 
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Figure 21.  (Top) Fiber diameter versus concentration measured with SEM, ESEM and 
permeability meter; n = 60 measurements; R2 values for the trend lines are 0.9854 for SEM 
and 0.7977 for permeability meter.  (Bottom) Pore area versus concentration measured with 
SEM, ESEM, and permeability meter; n = 40 measurements; R2 values for the trend lines are 
0.7764 for SEM and 0.5214 for permeability meter. 
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Tensile Testing 
 Previous uniaxial tensile testing performed on dry and cross-linked (hydrated) samples 
of a 60 mg/mL type II collagen electrospun mat indicated that a statistically significant 
difference existed between the dry (no treatment) samples and all of the cross-linked samples 
for peak stress, strain at break, and tangential modulus [129].  Since the type II collagen 
scaffolds will only be used in the cross-linked, hydrated state for any tissue engineering 
purposes, all biomechanical testing in this research was performed in the hydrated state.  
Figure 22 shows the stress-strain relationships of samples of each concentration of collagen 
electrospun.  These hydrated, cross-linked samples demonstrate uniaxial tensile behavior 
more characteristic of native tissue than do dry, uncross-linked samples.  Table 3 lists the 
values of the mechanical properties (means and standard deviations) for each electrospun 
concentration, and Figure 23 is presented to allow a quick comparison between these 
mechanical parameters.  Also shown in Table 3 are the corresponding mechanical properties 
for native articular cartilage tissue.  The values for peak stress and tangential modulus for the 
electrospun mats are at least an order of magnitude less than the values of these properties for 
native cartilage, while the values for strain at break for the electrospun mats are at least an 
order of magnitude greater than the value of this property for native cartilage.  At P<0.0001, 
there is a statistically significant difference between the mean values of peak stress for the 60 
mg/mL, 80 mg/mL, and 100 mg/mL concentrations and between the mean values of peak 
stress for 80 mg/mL, 100 mg/mL, and 120 mg/mL concentrations.  For strain at break 
calculations, both the 80 mg/mL and 120 mg/mL concentrations are significantly different 
from all of the other concentrations, while the 60 mg/mL and 100 mg/mL are not significantly 
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different from one another.  Statistical analysis of the tangential modulus data revealed that 
the 60 mg/mL and 120 mg/mL concentrations are significantly different from both the 80 
mg/mL and 100 mg/mL concentrations.   
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Figure 22.  Stress-strain curves for the cross-linked, electrospun mats of each concentration 
tested in uniaxial tension; n = 4. 
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Table 3.  Mechanical properties from uniaxial tensile testing (given as mean ± standard 
deviation) for each electrospun mat of type II collagen of each concentration. 
Electrospun Concentration Native 
60 80 100 120 Articular  
mg/mL mg/mL mg/mL mg/mL Cartilage 
Peak Stress (MPa) 0.35 ± 0.02 0.22 ± 0.03 0.17 ± 0.01 0.32 ± 0.03 1.3-4.4 [29] 
Strain at Break (%) 120 ± 10 150 ± 11 120 ± 4 93 ± 8 9.2-25.9 [29] 
Tangential Modulus (MPa) 0.55 ± 0.06 0.34 ± 0.05 0.32 ± 0.03 0.64 ± 0.09 5-25 [27-29] 
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Figure 23.  Average peak stress, tangential modulus, and strain at break for the type II 
collagen cross-linked, electrospun mats of each concentration tested in uniaxial tension; n = 4, 
error bars show standard deviation. 
 
Initial Cell-Seeding Investigation 
 The scaffolds placed both in the static culture and in the bioreactor had an initial cell 
density of 5x105 cells/mL media.  Photographs of the resulting histology can be seen in Table 
4.  Though cells do attach to the statically cultured scaffold, the cells do not grow on both 
sides of that scaffold.  However, in the bioreactor, the cells attach to both sides/surfaces of the 
scaffold and, hence, have more surface area to potentially migrate and proliferate more readily 
into the thickness of the scaffold.  From these results, the cell density used appeared to be 
77 
sufficient to obtain at least a monolayer of cells (though maybe not confluent) on most of the 
surfaces of the scaffolds within the bioreactor. 
 
Table 4.  Histology from the initial cell-seeding investigation; sections are stained with H&E. 
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Thickness of Cultured Tissue 
 The thickness measurements of the scaffold discs are presented in Figure 24.  When 
the thickness measurements of each concentration were analyzed statistically to determine any 
differences for each culture period, there were no statistical differences found except for the 
100 mg/mL concentration in which there was a significant difference between the control 
(week 0) and week 4 mean values.  In other words, the thickness values did not vary 
significantly over time for each concentration (with the one exception noted).  At each time 
period, there were significant differences determined: at week 0 the 60 mg/mL concentration 
was different from the 80 mg/mL and 120 mg/mL concentrations, the 80 mg/mL 
concentration was also different from the 100 mg/mL concentration, and the 100 mg/mL 
concentration was also different from the 120 mg/mL concentration; at week 2 all of the 
concentrations were significantly different from each other; at week 4 the 60 mg/mL 
concentration was different from the 80 mg/mL and 120 mg/mL concentrations, and the 100 
mg/mL concentration was different from the 120 mg/mL concentration; and at week 6 the 
significant differences were determined to be the same as at week 0.   
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Figure 24.  Thickness measurements of the scaffolds of each electrospun concentration before 
(week 0) and during tissue culture (weeks 2, 4, and 6); n = 3, error bars show standard 
deviation. 
 
 
Stress Relaxation 
 The results of the stress relaxation testing performed on the control samples and on the 
cultured tissue samples are given in Figure 25.  In general, there was a trend for all 
concentrations in which the equilibrium stiffness decreased from week 2 to week 6 of tissue 
culture.  For the 60 mg/mL concentration, the equilibrium stiffness mean value at week 0 was 
statistically significantly different from the mean values at week 4 and week 6.  There were no 
significant differences determined between the mean values for the different times periods for 
the 80 mg/mL and 120 mg/mL concentrations.  For the 100 mg/mL concentration, the only 
significant difference was between the mean values at week 2 and week 6.  At week 0 and 
week 4 there were no statistically significant differences between the concentrations.  
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However, at week 2 the 60 mg/mL concentration was significantly different from the 100 
mg/mL concentration; and at week 6 the 120 mg/mL concentration was significantly different 
from the other three concentrations.  Also tested in this method of stress relaxation were 
cartilage pieces removed from several locations on a calf femur, and the equilibrium stiffness 
from those tests was determined to be 0.60 ± 0.69 MPa; this value is about an order of 
magnitude greater than the values determined for the scaffolds.  The cartilage pieces tested 
were taken from different locations on the calf femur (front, back, middle), but there were no 
other samples available (i.e. a piece from the same location on the femur could not be tested 
multiple times); thus, this data is not included in the statistics.  Graphs of load and extension 
used to prepare the equilibrium stress versus strain curves (from which the equilibrium 
stiffness was determined) are given in Appendix D.   
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Figure 25.  Equilibrium stiffness determined from stress relaxation testing of the scaffolds of 
each electrospun concentration before (week 0) and during tissue culture (weeks 2, 4, and 6); 
n = 3, error bars show standard deviation. 
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Biochemical Analysis of Cultured Tissue 
 The results of the cell density analysis are presented in Figure 26.  In general, the trend 
is such that as concentration increases, cell density (i.e. cell number per mass of scaffold) 
decreases.  Cell density also appears to increase with time for each concentration.  From the 
statistical analysis by concentration, at week 2 the only significant differences are between the 
mean values of cell density for the 60 mg/mL concentration and the 80 mg/mL and 120 
mg/mL concentrations; at week 4 the only significant difference exists between the values for 
the 60 mg/mL concentration and the 120 mg/mL concentration; and at week 6 the 120 mg/mL 
concentration is significantly different from the other concentrations, and the 60 mg/mL 
concentration is also different from the 100 mg/mL concentration.  Statistical analysis by time 
period revealed no significant differences between the mean cell density values at the three 
time periods for the 60 mg/mL, 100 mg/mL, and 120 mg/mL concentrations; and for the 80 
mg/mL concentration the mean value at week 6 was significantly different from the values for 
week 2 and week 4.  The cell number seeded per mg scaffold mass is given in Figure 26.  for 
comparison, but it must be noted that this seeding was performed in the bioreactor media not 
directly on the surfaces of the scaffolds (refer to Methods section).   
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Figure 26.  Cell density (cell number per mg scaffold mass) for the scaffolds of differing 
electrospinning solution concentrations cultured for 2, 4, and 6 weeks; n = 3, error bars show 
standard deviation.  Week 0 is shown to give the number of cells seeded per mg scaffold mass 
(2.6x106 cells per scaffold were seeded in the bioreactors). 
 
 
 Overall, the results of the GAG analysis do not reveal any trends (Figure 27); neither 
the particular electrospun mat (i.e. a specific concentration) nor any particular time period of 
culture had any influence on the GAG content (represented as µg GAG per mg scaffold 
mass).  It should be noted that the control scaffolds (week 0) had some GAG content; thus, it 
is possible that the extraction process was not successful in completely removing all of the 
GAGs from the type II collagen.  From the statistical analysis, there are no significant 
differences between the mean values of GAG content for the different concentrations at any 
of the time periods (including week 0), nor are there any significant differences between the 
mean values of GAG content for each time at any one concentration.   
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Figure 27.  GAG content (µg per mg scaffold mass) for the scaffolds of differing 
electrospinning solution concentrations cultured for 0 (controls), 2, 4, and 6 weeks; n = 3, 
error bars show standard deviation. 
 
 
 Table 5 gives the mean values of the collagen content in the scaffolds determined via 
ELISA testing.  There are no statistically significant differences between any of the mean 
values of type I collagen content in the scaffolds in any of the analyses based on time period 
or electrospinning solution concentration.  For the type II collagen statistical analysis, at week 
6 the mean value of type II collagen content in the 100 mg/mL concentration is significantly 
different from all of the other concentrations.  Furthermore, for the 100 mg/mL concentration, 
the mean value of type II collagen content at week 6 is significantly different from the mean 
values of the same concentration at weeks 0, 2, and 4.  There are no other significant 
differences between the type II collagen values.  The type II/type I collagen ratio can not be 
calculated since there are no values of type II collagen and type I collagen content for 
corresponding time periods and concentrations (i.e. in the ratio calculations, either the 
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numerator or the denominator would always be zero).  A spike and recovery study was 
performed to test the protocol used to detect type II collagen; the standard provided in the 
ELISA kit was added to several samples without cells and tested alone at a known 
concentration.  The spiked samples gave readings equal to the reading of the standard alone.  
Thus, the standard is working but the collagen in the samples is either at undetectable levels 
(unlikely since the scaffolds are composed of type II collagen) or is not being detected by the 
antibody that was raised against the collagen molecules in the standard.   
 
Table 5.  Collagen content (µg per mg scaffold mass) for the scaffolds of differing 
electrospinning solution concentrations cultured for 0 (controls), 2, 4, and 6 weeks; values are 
given as mean ± standard deviation, n = 3. 
 Concentration (mg/mL) Week 0 Week 2 Week 4 Week 6 
60 0 0 0 0 
80 0.00053 ± 0.00092 
0.00112 ± 
0.00102 
0.00344 ± 
0.00296 
0.00040 ± 
0.00041 
100 0.00027 ± 0.00047 
0.00048 ± 
0.00022 
0.00231 ± 
0.00240 
0.00638 ± 
0.00104 
Type II 
Collagen 
(µg/mg) 
120 0 0 0 0 
60 0 0 0 0.00049 ± 0.00062 
80 0 0 0 0 
100 0 0 0 0 
Type I 
Collagen 
(µg/mg) 
120 0 0 0.00003 ± 0.00006 0 
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Histological Analysis of Cultured Tissue 
 Representative photographs were taken of the histology slides and are given in Table 
6, Table 7, Table 8, and Table 9 for the 60 mg/mL, 80 mg/mL, 100 mg/mL, and 120 mg/mL 
concentrations, respectively.  For all of the concentrations, pictures were taken of the control 
scaffolds, without cells, for comparison purposes.  Some general comments are given below 
describing the observations made on all of the scaffolds. 
 
60 mg/mL Concentration 
 For the 60 mg/mL concentration at week 2, one side of the scaffold usually had more 
cells on it than the other side; there was not much infiltration of the cells into the scaffolds 
unless there was a large void or pocket present.  Some of the cells were spheroid in shape and 
some were elongated.  It was typical to find clumps of cells especially on the side of the 
scaffold with more cells.  For the most part, there was a solid layer of cells on both sides of 
the scaffolds.  At week 4, the observation was made that when the cells are in clusters, they 
appeared more spheroid in shape; but when the cells are in a monolayer on the scaffold, they 
appeared more elongated.  Also, the cells that have infiltrated the scaffold appear to be more 
spheroid than the cells lining the outside of the scaffold.  There was very little cellular 
infiltration unless a path (such as a tear or void) was available.  At week 6 there appeared to 
be an abundance of cells on one side, and only one or two layers of cells on the other side 
across the entire length of the scaffold.  There were numerous spheroid cells, and cellular 
infiltration into the scaffold did occur though not through the entire thickness; the infiltration 
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was from the direction with the most cells.  There were also a few areas of lighter blue visible 
in the Masson’s Trichrome-stained section possibly indicating new collagen production.   
 
80 mg/mL Concentration 
 For the 80 mg/mL concentration at week 2, there are some cell clusters and thin layers 
of cells lining both sides of the scaffolds, with one side having a layer greater than two cells in 
thickness and the other side having a layer less than or equal to two cells in thickness.  The 
cells tended to follow the contours of the scaffold, and most of the cells appeared elongated.  
There are some pockets of spheroid cells and some light blue areas seen in the sections 
stained with Masson’s Trichrome (possibly indicating new collagen production).  There is 
some cellular infiltration from the direction of the side with the most cells; most cellular 
infiltration occurred where there is a path for the cells to move along.  Clusters of cells 
appeared to be moving into openings on the ends of the scaffolds between the layers created 
by electrospinning; this is interesting because these sections were punched out of the 1 cm 
disc, so the ends are not exposed before punching (though the punches are made near the edge 
of the 1 cm disc).  At week 4 it was observed that the cells formed a confluent layer on both 
sides of the scaffold.  No cellular infiltration was observed and there were no significant areas 
of light blue visible in the Masson’s Trichrome-stained sections.  There were some spheroid 
cells, but most cells appeared elongated.  At week 6 two of the samples displayed clusters of 
cells on one side of the scaffold and only a thin layer of cells on the other side, while the other 
sample only had thin layers of cells with no clusters.  There was cellular infiltration from the 
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direction of the side with the most cells (i.e. clusters of cells), and there were areas of light 
blue seen around the cell clusters in the Masson’s Trichrome-stained sections.   
 
100 mg/mL Concentration 
 For the 100 mg/mL concentration at week 2, there were thin confluent layers of cells 
on both sides of the scaffolds that appeared spheroid in shape and more evenly distributed (i.e. 
there were no clusters of cells visible).  There was very little to no cellular infiltration seen but 
there were cells lining the delaminated surfaces of the scaffold, and there were a few light 
blue areas in the Masson’s Trichrome-stained sections (possibly indicating new collagen 
production).  At week 4 there were still somewhat thin cell layers on both sides of the scaffold 
with a few cell clusters and very little cellular infiltration.  Both spheroid and elongated cells 
were seen, and some blue areas are visible in the Masson’s Trichrome-stained sections.  
Where there were larger gaps or crevices on the surface, more cells aggregated.  On one 
sample there were cells in the middle of the scaffold as well as in thin layers on the top and 
bottom of the scaffold; this was interesting because there was no clear path through the 
thickness of the scaffold for the cells to have migrated into the middle of the scaffold.  At 
week 6 the sections contained numerous cell clusters and some cellular infiltration especially 
where the scaffold geometry was not solid; the rest of the scaffold surfaces (both sides) were 
covered by thin layers of cells (several cells in thickness) with much less cellular infiltration.  
The amount of spheroid cells outnumbered the elongated cells.  There were some blue areas 
seen in the Masson’s Trichrome-stained sections.   
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120 mg/mL Concentration 
 For the 120 mg/mL concentration at week 2, there were very thin layers of cells lining 
the top and bottom surfaces of the scaffolds, with the cell layer on one surface slightly thicker 
than the layer on the other surface.  One sample did delaminate and there may have been a 
few cells on the delaminated surfaces.  Cellular infiltration was almost nonexistent except for 
the one Masson’s Trichrome-stained sample in which cells appeared in the middle of the 
scaffold with no clear path of migration from either side (i.e. top or bottom) of the scaffold; 
these cells had a spheroid appearance.  At week 4 there appeared to be confluent cell layers on 
both sides of the scaffold with one layer several cells in thickness and the other layer only a 
monolayer of cells.  Several samples have very contoured surfaces.  The cell shape was 
difficult to determine, though most appeared to be elongated, and there did not appear to be 
any cellular infiltration.  One sample had a small cluster of cells on one surface with very 
minimal infiltration into the scaffold at that cluster.  There were a few cells observed in the 
middle of two sections stained with Masson’s Trichrome.  At week 6 the samples had thin, 
mostly confluent layers of cells on both sides of the scaffolds, either a monolayer or several 
cells in thickness.  There were some spheroid cells, but the majority appeared elongated.  
There was a sample with cells in the middle of the scaffold with an opening on one edge of 
the scaffold (a possible path for cellular migration).  Only a very small area of the light blue 
staining was visible in one sample stained with Masson’s Trichrome. 
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Table 6.  Histology for the 60 mg/mL concentration for each culture period; H&E and 
Masson’s Trichrome stains are represented at 10x, 20x, or 40x magnifications. 
WEEK 0 
No cells 
H&E, 20x H&E, 40x Masson’s Trichrome, 20x 
Sa
m
pl
e 
1 
H&E, 20x H&E, 40x Masson’s Trichrome, 40x 
Sa
m
pl
e 
2 
H&E, 20x Masson’s Trichrome, 20x 
 
WEEK 2 
Sa
m
pl
e 
3 
H&E, 20x Masson’s Trichrome, 10x Masson’s Trichrome, 40x 
WEEK 4 
Sa
m
pl
e 
1 
H&E, 10x Masson’s Trichrome, 20x 
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Sa
m
pl
e 
2 
H&E, 20x H&E, 40x Masson’s Trichrome, 40x 
 
Sa
m
pl
e 
3 
H&E, 20x H&E, 20x Masson’s Trichrome, 20x 
Sa
m
pl
e 
1 
H&E, 20x 
H&E, 10x 
H&E, 40x Masson’s Trichrome, 20x 
Sa
m
pl
e 
2 
H&E, 20x Masson’s Trichrome, 20x Masson’s Trichrome, 40x 
WEEK 6 
Sa
m
pl
e 
3 
H&E, 20x H&E, 40x Masson’s Trichrome, 10x 
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Table 7.  Histology for the 80 mg/mL concentration for each culture period; H&E and 
Masson’s Trichrome stains are represented at 10x, 20x, or 40x magnifications. 
WEEK 0 
No cells 
H&E, 20x Masson’s Trichrome, 20x 
 
Sa
m
pl
e 
1 
H&E, 10x Masson’s Trichrome, 20x Masson’s Trichrome, 40x 
Sa
m
pl
e 
2 
H&E, 10x H&E, 40x Masson’s Trichrome, 20x 
WEEK 2 
Sa
m
pl
e 
3 
H&E, 40x Masson’s Trichrome, 10x 
 
WEEK 4 
Sa
m
pl
e 
1 
H&E, 20x Masson’s Trichrome, 20x 
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Sa
m
pl
e 
2 
H&E, 10x H&E, 40x Masson’s Trichrome, 20x 
 
Sa
m
pl
e 
3 
H&E, 20x Masson’s Trichrome, 10x 
 
Sa
m
pl
e 
1 
H&E, 10x H&E, 40x Masson’s Trichrome, 10x 
Sa
m
pl
e 
2 
H&E, 10x Masson’s Trichrome, 20x Sample 3: H&E, 10x 
WEEK 6 
Sa
m
pl
e 
3 
H&E, 40x H&E, 40x Masson’s Trichrome, 20x 
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Table 8.  Histology for the 100 mg/mL concentration for each culture period; H&E and 
Masson’s Trichrome stains are represented at 10x, 20x, or 40x magnifications. 
WEEK 0 
No cells 
H&E, 20x H&E, 40x Masson’s Trichrome, 20x 
Sa
m
pl
e 
1 
H&E, 10x H&E, 20x Masson’s Trichrome, 20x 
Sa
m
pl
e 
2 
H&E, 20x H&E, 40x Masson’s Trichrome, 20x 
WEEK 2 
Sa
m
pl
e 
3 
H&E, 20x Trichrome, 10x Masson’s Trichrome, 20x 
WEEK 4 
Sa
m
pl
e 
1 
H&E, 10x H&E, 40x Masson’s Trichrome, 40x 
94 
Sa
m
pl
e 
2 
H&E, 20x Masson’s Trichrome, 20x Masson’s Trichrome, 40x 
 
Sa
m
pl
e 
3 
H&E, 20x Masson’s Trichrome, 20x 
 
Sa
m
pl
e 
1 
H&E, 10x H&E, 20x Masson’s Trichrome, 10x 
Sa
m
pl
e 
2 
H&E, 20x Masson’s Trichrome, 20x Masson’s Trichrome, 40x 
WEEK 6 
Sa
m
pl
e 
3 
H&E, 10x Masson’s Trichrome, 20x Masson’s Trichrome, 40x 
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Table 9.  Histology for the 120 mg/mL concentration for each culture period; H&E and 
Masson’s Trichrome stains are represented at 10x, 20x, or 40x magnifications. 
WEEK 0 
No cells 
H&E, 10x (half, delaminated) H&E, 40x Masson’s Trichrome, 20x 
Sa
m
pl
e 
1 
H&E, 40x (one side) H&E, 40x (opposite side) Masson’s Trichrome, 20x 
Sa
m
pl
e 
2 
H&E, 10x H&E, 40x Masson’s Trichrome, 20x 
WEEK 2 
Sa
m
pl
e 
3 
H&E, 40x Masson’s Trichrome, 20x Masson’s Trichrome, 40x 
WEEK 4 
Sa
m
pl
e 
1 
H&E, 10x Masson’s Trichrome, 20x 
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Sa
m
pl
e 
2 
H&E, 20x H&E, 40x Masson’s Trichrome, 20x 
 
Sa
m
pl
e 
3 
Trichrome, 20x Masson’s Trichrome, 40x 
 
Sa
m
pl
e 
1 
H&E, 10x H&E, 40x Masson’s Trichrome, 20x 
Sa
m
pl
e 
2 
H&E, 10x H&E, 40x Masson’s Trichrome, 20x 
WEEK 6 
Sa
m
pl
e 
3 
H&E, 20x H&E, 40x Masson’s Trichrome, 10x 
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Discussion 
 
Cross-linking Electrospun Collagen 
 Electrospun collagen fibers consist of reconstituted collagen fibrils (i.e. acid 
soluble collagen extracted from fetal calf cartilage) that are formed via both the 
electrospinning fabrication process and possibly via the spontaneous organization of 
collagen molecules [143].  These electrospun collagen fibers are potentially similar in 
ultrastructure to native collagen; however, the fibers are fragile, possibly due to a lack of 
native cross-links resulting in weakly bonded fragments of collagen molecules.  Thus, the 
electrospun structures need further treatment to stabilize the material.  Further cross-
linking, beyond what little weak bonding may have spontaneously occurred, is necessary 
in order to work with an electrospun collagen scaffold in a hydrated state for tissue 
engineering applications.  The heterobifunctional reagent EDC was used to introduce 
synthetic cross-links that form a bridge between two amino acids without imparting any 
other chemistry to the collagen molecule.  Within the triple helical structure of collagen, 
there are a large number of opportunities for lysine interactions with aspartic acid and with 
glutamic acid residues; thus, cross-links created by EDC can be formed within an α chain, 
between α chains, between collagen molecules, or between collagen fibrils [127].   
 To avoid the disintegration or fragmentation of the electrospun structures, ethanol 
was utilized as the cross-linking solvent and the proton donor for the EDC reaction instead 
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of a buffered solution; this is the unique aspect of the cross-linking protocol used in this 
research.  Ethanol molecules in concentrated solutions associate via hydrogen bonding, the 
energy of which is comparable to that of the hydrogen bonding of water [144].  
Furthermore, the ethanol molecule has little steric hindrance and can interact with and 
hydrogen bond to chemical groups in tissues, including carbonyl oxygen, amine, and 
amide nitrogen, i.e. the O and N atoms in peptide bonds [144, 145].  Additionally, solvents 
of a lower dielectric constant (35 for ethanol compared to a value of 81 for water) reduce 
the dipolar forces resulting in a change in the bonding; the salt bridges (due to oppositely 
charged groups) of fibrous proteins in an aqueous solution will be converted to hydrogen 
bonds when immersed in alcohol solutions [144, 145], which may be advantageous in 
maintaining the electrospun collagen mat structure.  Further support for the greater 
performance of the electrospun collagen mats immersed in ethanol compared to water is 
that ethanol molecules in concentrated solutions hydrogen bond to one another and can 
form polymeric chains [144], which may help stabilize the electrospun collagenous 
structure.  Also, the ethyl group of the solvent could interact through hydrophobic 
interactions with the collagen surface [146, 147]; the hydroxyl group is then available to 
interact with other ethanol molecules or other residues in the protein to again stabilize the 
electrospun collagenous mat structure.  The critical issue involved in this study was not to 
provide better reactivity of groups, but to provide the condition that maintained the proper 
structure of the mat.  Ethanol provided that condition since it was not possible to use a 
buffered solution.   
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Some shrinkage in overall dimensions of the electrospun mats was observed with 
the EDC cross-linking treatment.  This shrinkage (between 12 and 33% decrease in 
dimensions) is probably due to the absorption of moisture by the agents during 
measurement of the solids prior to cross-linking and the subsequent reaction of the fibrous 
collagen to slight hydration.   
 
Scaffold Morphology and the Interaction with Chondrocytes 
 The type II collagen electrospun scaffolds supported chondrocyte attachment and 
possible proliferation on the surface of the scaffolds.  Cell adhesion, spreading, and shape 
have been shown to be influenced by scaffold morphology; thus, fiber diameter, porosity, 
pore size, and pore interconnectivity and tortuosity in a scaffold can influence cell behavior 
and serve to orient cells [148].  The average diameters of the fibers in the scaffolds of all 
concentrations ranged between about 100 to 620 nm; this scale is comparable to that of the 
native ECM.  Thus, the electrospun collagen provided the size and chemical composition 
the cells would see in vivo.   
 There was a statistically significant difference found in the fiber diameter 
measurements of the 60 mg/mL concentration in the dry, untreated state (measurement 
made using a digitized image of a scanning electron micrograph) and in the hydrated, 
cross-linked state (measurement made using a digital picture).  This could be a result of the 
cross-linking procedure binding collagen fibrils together to increase fiber diameter or a 
result of some swelling due to the hydration or a combination of both.  Further 
investigation is needed.   
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 A large pore volume (i.e. porosity) allows sufficient space for cells to grow into 
tissues and for nutrients and wastes to diffuse in and out, respectively.  The average 
porosity of the scaffolds used in this research ranged between 84 and 89%.  These values 
are just below the suggested minimum porosity of 90% (considered highly porous, and 
there has been suggestion of a 95% or greater porosity needed for chondrocytes [91]), 
which is believed to provide sufficient space for cellular infiltration where the cells 
perform actively and exchange nutrients and wastes with the environment [84, 149].  This 
parameter must be considered in conjunction with the other scaffold design parameters. 
 It has traditionally been thought that the minimum pore size is dependent on the 
diameter of the cell in the tissue to be regenerated [150].  Pores smaller in diameter than 2 
nm only allow small molecules such as gases to penetrate; small proteins are able to pass 
through pores with diameters between 2 nm and 50 nm; larger proteins and molecules can 
penetrate pores with diameters greater than 50 nm; and cells can migrate when pore sizes 
exceed 1 µm [113].  Mooney and Langer state that pores greater than 10 µm in diameter 
are necessary for a scaffold to become incorporated into the host tissue, though Matthews 
et al. have shown that an electrospun scaffold, with pore sizes 50 times smaller than that 
described by Mooney and Langer, resulted in migration and dense population of aortic 
smooth muscle cells throughout the scaffold [99].  However, the behavior of chondrocytes 
in such a scaffold may not be the same as that seen with smooth muscle cells.  On an 
additional note regarding pores, a uniform pore structure and distribution has been shown 
to have better mechanical properties [91]. 
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 Pores in an electrospun scaffold constitute the spaces formed between the fibers 
that collect on the target during the electrospinning process.  Because the mat that is 
created is nonwoven, it is believed that there is the potential for cells to push the fibers 
around during migration such that the cells essentially dictate the pore size and distribution 
desirable for a particular cell behavior [84].  In this research, approximate pore diameters 
of the electrospun mats were calculated from the average pore areas measured using the 
imaging software on the scanning electron micrographs, and these values ranged between 
1.5 and 2.0 µm for the dry and hydrated mats of varying concentrations.  These values are 
significantly greater than the pore diameters determined using the permeability data, which 
ranged between 0.02 and 0.06 µm.  The pore area measurement from the scanning electron 
micrographs is very subjective; it is quite difficult to determine actual pores in a two-
dimensional picture; thus, the calculations from the permeability data may be more 
accurate.   
 The pore sizes determined from the permeability data (0.02 to 0.06 µm) more 
closely match but are still greater in size than the pores formed by collagen and 
proteoglycans in healthy articular cartilage, the size of which ranges from 25 to 75 Å [14].  
Though this pore-size scale will limit what passes through the scaffold (more like the 
native tissue), perhaps this pore-size scale is too small for chondrocytes to infiltrate the 
scaffolds.  As seen in the histology photographs, the scaffolds do appear as dense mats of 
collagen with a few large voids and some areas of delamination (depending on the 
concentration), but in general there is very little cellular infiltration perhaps due to the 
relatively small pore size.   
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 Healthy articular cartilage has a very low permeability, which ranges from 10-16 to 
10-15 m4/N·sec [12, 14, 32].  The mean values of electrospun mat permeability calculated in 
this research range from 0.000682 to 0.00350 D or from 7.6x10-13 to 3.9x10-12 m4/N·sec, 
which are at least 2 orders of magnitude greater than the permeability of normal articular 
cartilage.  In fact, the permeability of the electrospun mats is closer to but still greater than 
that for degenerated cartilage (which is on the order of 10-14 m4/N·sec) [12, 14, 32].  The 
permeability of the type II collagen electrospun mats in this study is comparable to the 
mean permeability (about 1.25x10-12 m4/N·sec) determined for non-woven mesh PGA 
scaffolds commonly used in cartilage tissue engineering [151]. 
 On an additional note, prior to seeding, the scaffold dry weights (all collagen) were 
(on average) approximately 10% of the scaffold wet weights.  This illustrates the sponge-
like capacity of the electrospun scaffolds; in other words, the scaffolds displayed a swollen 
behavior upon hydration.  Furthermore, to compare the unseeded scaffolds to native 
articular cartilage tissue, water constitutes greater than 60% of the tissue by wet weight and 
type II collagen about 20% by wet weight.   
 
Histology and Biochemical Analyses 
 Chondrocytes cultured in monolayer did take on the fibroblast-like, flattened 
morphology.  Thus, there is the possibility of dedifferentiation during the static culture.  
Upon transfer of the chondrocytes to the bioreactor for dynamic culture on the scaffolds, 
redifferentiation media was not used.  The hypothesis being tested was that growing the 
cells on the three-dimensional electrospun type II collagen fibrous scaffolds would result 
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in the cells reexpressing, and possibly redifferentiating into, the chondrocytic phenotype 
and their spheroid morphology.  The tissue structure created in this research resembled the 
superficial zone more than the middle zone.  The collagen fibrils are oriented tangentially 
to the scaffold surfaces (with no fibers oriented perpendicular to the surfaces) and some 
cells are elongated in shape, both are characteristics of the superficial zone.   
 The results of the histology give some insight into the effects of scaffold 
morphology on cell growth and cellular infiltration.  There were numerous cell aggregates 
(cell clusters) especially in crevices on the surfaces of the scaffolds.  The cells in these 
clusters appeared more spheroid in shape whereas the cells in the thin layers (one to only a 
few cells in thickness) usually appeared elongated.  The formation of such cell clusters has 
been observed inside tissue-engineered matrices by others studying the in vitro 
regeneration of articular cartilage [90]. 
 It has been shown by Vunjak-Novakovic et al. that dynamic cell seeding results in a 
more uniform distribution of cells throughout the scaffold, and higher seeding cell numbers 
have been associated with high rates of cartilage matrix production (partially attributed to 
greater opportunities for cell-to-cell and cell-to-matrix interactions) [138, 152].  It is 
believed that an uneven distribution of cells may lead to an inhomogeneous repair tissue 
which is unacceptable in cartilage repair.  To date a homogeneous cell distribution has 
been best achieved in the gel matrix [153].  The initial cell seeding study performed as part 
of this research demonstrated that cells attached to both sides of the scaffolds with 
dynamic cell seeding in the bioreactor environment.  However, the histology results here 
show that there were always more cells on one side/surface of the scaffolds than on the 
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other side/surface.  In a few sections, there is some cellular infiltration from the direction 
of the side with the most cells.  The seeding density used in this research definitely resulted 
in the attachment of cells to all scaffolds, but no conclusions can be made at this point 
about the effects on matrix production (as described below). 
 There was only one statistically significant change in thickness over time and that 
was for the 100 mg/mL concentration between week 0 and week 4, though this finding can 
not sufficiently be explained by the other results (biochemical, mechanical, or 
histological).  The reason for the lower thickness of the 100 mg/mL concentration 
compared to the 80 mg/mL concentration could be explained by the loss of fibers during 
the electrospinning process (which is known to be affected by changes in temperature, 
humidity, and extraneous electrical interferences).   
 The main observation made regarding cell migration is that most cellular 
infiltration into the scaffold occurred where there is a path for the cells to move along.  
Such a path could be a tear or a large void or pocket along the surface of the scaffold or an 
area of delamination (separation of the layers of fibers sometimes created during 
electrospinning) on the edge of the scaffold disc.  Clusters of cells appeared to be moving 
into the openings on the edges of some of the 3 mm diameter scaffolds.  This is interesting 
because these sections were punched out of the 1 cm cultured disc, so the ends are not 
exposed before punching; however, these 3 mm discs are punched from near or on the edge 
of the 1 cm disc so it is possible the cells had time to migrate into the scaffolds from the 
edge over the 2, 4, or 6 week culture period.  Migration occurring from the edges of the 
scaffolds may also be because the matrix is a layering of fibers in two dimensions; cells 
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moving in from the edge can follow one fiber into the scaffold rather than moving from 
fiber to fiber (as the cells would during migration from the surface into the thickness). 
 The number of chondrocytes per mg of cartilage (wet mass) has been shown to be 
between 26,000 and 78,000 chondrocytes/mg [154].  This finding is much lower than most 
of the cell density values determined in this research with the exception of the 120 mg/mL 
concentration and the 80 mg/mL and 100 mg/mL concentrations at week 2.  In viewing the 
histological slides, there did appear to be more cells in the 60 mg/mL, 80 mg/mL, and 100 
mg/mL concentrations; this finding does correlate with the DNA analysis results which 
showed that the 120 mg/mL concentration over all three culture periods resulted in the 
lowest cell density.  The general trend is that cell density increased over time, thereby 
indicating proliferation on the collagen scaffolds.  This trend does seem to be supported by 
the histology.  Several of the cell density mean values have quite large standard deviations, 
possibly indicating poor uniformity of cell distribution.  One note needs to be made 
regarding cell density: in measuring the DNA content in the scaffold samples, an excitation 
wavelength of 320 nm had to be used even though the Hoechst 33258 dye excites at 365 
nm and an emission wavelength of 460 nm had to be used despite an emission peak at 458 
nm for the Hoechst 33258 dye.  This was due to the limitations of the instrument available.  
Though the wavelengths used are not exactly at the peaks of the spectra for this dye, the 
widths of the spectra are such that analysis was still possible.   
 The GAG content measured in this research represents that deposited on/within the 
collagen scaffold, and was much lower than a reported range of GAG content in articular 
cartilage found to be between 22 and 38 µg/mg of cartilage (wet mass) [154].  The GAG 
106 
content did not increase over time in any of the concentrations as was expected.  In fact, 
there are no statistically significant differences between any of the GAG contents in any 
one concentration over the different culture periods, nor are there any differences between 
the GAG contents in any one culture period over the different concentrations.  Thus, it may 
be possible that the cells did not reexpress the chondrocytic phenotype despite the 
appearance of spheroid-shaped cells particularly in the 60 mg/mL, 80 mg/mL, and 100 
mg/mL concentrations.  There is an explanation for the appearance of GAGs in the control 
scaffolds that contain no cells.  Though the purity of the collagen samples was consistent 
with the type II collagen standard supplied by the University of Tennessee, RDRCC 
Collagen Core Center [134], there may still be the presence of proteoglycans that were not 
removed in the collagen extraction process.  The molecular weight of the backbone core 
protein is around 250,000 and that of chondroitin sulfate is about 20,000; there is an 
average of 80 chondroitin sulfate chains present in a typical cartilage proteoglycan [155].  
Thus, this high molecular weight would not appear on the gel used in the SDS-PAGE in 
this research.   
 The collagen synthesis detected by the ELISA tests was minimal.  Only the 80 
mg/mL and 100 mg/mL concentrations showed any type II collagen present.  From those 
results, the values of type II collagen content that aren’t essentially zero are those values 
for the 80 mg/mL concentration at weeks 2 and 4 and those for the 100 mg/mL 
concentration at weeks 4 and 6.  The histology (Masson’s trichrome-stained sections) 
revealed the presence of collagen, by way of light blue staining, in the 80 mg/mL 
concentration at weeks 2 and 6 and in the 100 mg/mL concentration at weeks 4 and 6; 
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these results do correlate with the results of the type II collagen ELISA test.  Very slight 
areas of blue staining were seen in the 60 mg/mL concentration at week 6 and in the 120 
mg/mL concentration at week 6.  The type I collagen ELISA test did detect type I collagen 
in these two concentrations (60 mg/mL and 120 mg/mL) though the mean values are very 
close to zero.  Though type II collagen was not produced in large quantities, it is good that 
type I collagen was not produced.  This could potentially mean that the cells have not 
changed phenotypes; however, they are not actively making their own matrix. 
 It is very interesting that the type II collagen ELISA did not detect the collagen that 
comprised the scaffold itself – this is shown by the zero reading (or essentially zero) for 
the control scaffolds at week 0.  The lyophilized collagen (at the stage prior to dissolution 
in HFP and subsequent electrospinning) is detected by the ELISA and, in fact, results in a 
standard curve closely matching that created by running the standard provided in the kit.  
Further tests are underway to understand if the electrospinning process or possibly the 
cross-linking process transforms the collagen in such a manner as to mask the epitopes 
detected by the ELISA kit antibodies.  Type II collagen dissolved in HFP as well as 
electrospun type II collagen were detected by the ELISA kit though the concentrations 
(including the standards run in this particular test) were not what were expected (i.e. 
known concentrations were prepared and tested) – since an already-opened kit was used, it 
is possible that the thawed, re-frozen, and thawed antibodies were no longer stable.  The 
spike and recovery test revealed that the spiked samples gave readings equal to the reading 
of the standard alone.  Thus, the standard is working but the collagen in the samples is 
either at undetectable levels (unlikely since the scaffolds are composed of type II collagen) 
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or is not being detected by the antibody that was raised against the collagen molecules in 
the standard.  This test showed that the sample preparation is sufficient since the standard 
was recovered from the samples (i.e. nothing in the preparation is hindering the binding of 
the standard), but the collagen molecules in the samples won’t bind to the kit antibody.  
The cross-linking effect of EDC could have rendered a conformational change (to the type 
II collagen in the electrospun mat) that has hindered/inhibited the binding to the epitopes 
by the antibodies (provided in the ELISA kit) that are specific to those epitopes of native 
type II collagen.  Such a conclusion was made with porcine dermal collagen membranes 
treated with glutaraldehyde [156].  An interesting study would be to recharacterize the 
cross-linked, electrospun type II collagen scaffolds by developing a new antibody for these 
scaffolds that would recognize and bind to the new epitopes/surface residues available in 
these scaffolds.  Testing the new antibody versus the original antibody (from the kit, that 
recognizes native type II collagen epitopes) may prove to be insightful.   
 
Scaffold Mechanical Properties 
In native tissue, at small extensions, there is a non-linear toe region in which 
collagen fibers are realigning, and at larger extensions, the aligned collagen fibers are 
stretched collectively thereby contributing to the stiffness observed in the curve [27].  The 
same phenomenon is occurring in the cross-linked, electrospun, non-woven mats, in which 
the randomly-oriented collagen fibers first align themselves at small extensions and are 
collectively strained at larger extensions.   
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The stiffness of the structure as a whole depends on fiber diameter and orientation, 
number of fibers, and the strength of covalent cross-links and noncovalent bonds (i.e. type 
and amount).  The tensile material properties do not follow a particular trend in this 
research.  The diameter and pore area measurements determined from the permeability 
meter show that the mean values increase with concentration with the exception of the 120 
mg/mL concentration, which showed a decrease to values below that of the 100 mg/mL 
concentration.  There may be a concentration threshold at which the collagen molecules 
can no longer form fibers of larger diameters.  Additionally, alignment was not controlled 
because a random arrangement of fibers was the desired effect.  Though no control efforts 
were made, the increasing diameters may have had an effect on the arrangement of the 
fibers; this alignment needs to be measured in future work.  All of the cross-linked, 
electrospun mats tested in this research demonstrated values of peak stress and tangential 
modulus at least an order of magnitude less than those reported for cartilage tissue, and the 
strain at break values of the electrospun mats were at least an order of magnitude greater 
than the value of this property for native cartilage tissue.  Though it must be kept in mind 
that these differences reflect variances between a simulated ECM alone versus whole 
tissue, it does bode well for the use of electrospun type II collagen mats in the tissue 
engineering of cartilage in that during tissue regeneration in vitro, the stiffness of the 
electrospun scaffold should not inhibit chondrocyte mobility, and the electrospun fibers 
should be free to be moved by the cells themselves [101].  However, this was not the case 
in this research; the cells did not appear to move the fibers so that cellular infiltration could 
occur rapidly. 
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The cross-linked, electrospun scaffolds maintained their structural integrity during 
the 6 weeks of culture such that they could still be easily manipulated with forceps.  Such 
capacity to maintain strength favors these scaffolds over collagen gels for use in cartilage 
tissue engineering.   
 In the stress relaxation test, a constant displacement is applied to the specimen 
surface and the resulting stress within the tissue is measured.  During the ramp phase of the 
displacement, the tissue is compressed at a constant rate, fluid exudation occurs and the 
solid ECM is compacted.  During the relaxation phase, once the desired displacement is 
attained and the compressive strain is held constant, fluid and stress redistribution occurs 
within the specimen until an equilibrium is achieved (i.e. a homogeneous state of 
compression is achieved).  This method (with indentation) was selected because of the 
anticipated limited thickness of the cultured tissue and the requirement to not disturb the 
surrounding tissue since it was to be used in other biochemical testing and histology.  
There were no statistically significant differences between the equilibrium stiffness values 
of the controls (week 0); thus, the electrospinning solution concentration (and hence the 
fiber diameter and pore size) did not have an influence on the equilibrium stiffness.  
Culture time also had little to no influence as shown by the few statistical differences that 
do not follow any particular pattern.  One point of interest is that at week 6 the 120 mg/mL 
concentration is significantly different from all of the other concentrations; this correlates 
well with the finding that the 120 mg/mL concentration had the lowest cell density, which 
was significantly different from the cell densities of all of the other concentrations.  The 
trend that the mean equilibrium stiffness decreases from week 2 to week 6 may be related 
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to the cell density trend in which the mean cell density increases from week 2 to week 6 
(with the exception of the 120 mg/mL concentration).  Thus, a decrease in equilibrium 
stiffness may be related to an increase in cell density.  Very little degradation, if any, is 
suspected over the 6 week culture period because the pore structure appeared the same at 
week 6 as at week 0 per the histological analysis.  However, it is possible that there was 
some slight degradation occurring in the scaffolds which may account for the general 
decreasing trend in equilibrium stiffness over time.  The exact degradation rate has yet to 
be determined.   
 Mechanical stimulation via hydrodynamic forces in the rotating chambers of the 
bioreactor during in vitro cultivation is proposed to more closely resemble some of the 
aspects of the dynamic loading on cartilage in vivo and has been shown to result in the 
production of the cartilaginous matrix components GAG and type II collagen with uniform 
distribution in some tissue-engineered constructs [56].  In the research presented here it is 
not clear if the dynamic bioreactor environment had any influences on the mechanical 
properties or biochemical compositions of the scaffolds.  It is possible that greater 
hydrodynamic loading is necessary to stimulate the cells on these scaffolds that were found 
to be stiffer than native cartilage.  In any case, the benefits of being able to control the 
conditions of cell seeding and culture environment more easily in the bioreactor were 
appreciated in this research. 
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Conclusions and Future Work 
 
 The electrospun type II collagen mats created for this research have the desired 
fibrous structure (on the scale of native ECM) and possess mechanical properties 
(following cross-linking) that enable handling and use in culture conditions.  Based on the 
biochemical results in conjunction with the histology, the cell proliferation and 
biosynthetic activity of the chondrocytes was not influenced (to a statistically significant 
level) by electrospinning solution concentration (i.e. fiber diameter and pore size) or by 
time in culture.  In fact, very little if any biosynthetic activity (GAG and collagen 
synthesis) was observed in this research.  While the cells are still proliferating, there will 
be minimal production of matrix components.   
 It is possible that, following the extraction process involving the use of pepsin that 
digests and removes the telopeptide ends, the product remaining is type II atelocollagen 
[90]; this is no longer the ordered fibril form that existed before the extraction process.  
After electrospinning, the mat may be more of a filamentous structure rather than 
composed of collagen fibrils (of an ordered structure) because of a lack of native 
crosslinks.  Hence, the structure may be in the monomeric form.  The EDC is used to 
cross-link the electrospun mat such that it has sufficient mechanical integrity to withstand 
tissue culture conditions.  It would be of interest to know if the lack of native crosslinks, 
which in turn does not allow the formation of purely native type II collagen fibrils, 
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interferes with cell signaling in any way.  Thus, further investigation into the exact 
chemical structure of the cross-linked, electrospun type II collagen molecules should be 
performed in an effort to better understand the cell-matrix interactions.   
 Though the chemical composition may not be exactly native type II collagen, the 
first action item for future work should be investigating the scaffold design.  The 
electrospun mats that underwent the studies in culture were used in the physical state they 
were in when removed from the mandrel (with cross-linking and subsequent swelling upon 
hydration).  The results of this research showed very little cellular migration into the 
scaffold thickness and very little matrix biosynthetic activity, which could be because the 
cells remained on the surface of the scaffolds and grew outward from the scaffold, thereby 
really only participating in cell-to-cell interactions.   
 Most of the studies that have had some successes in stimulating the production of 
cartilaginous tissue (i.e. engineered cartilage) have utilized scaffolds with large 
interconnected pores, in the range of 50 to 300 µm.  The electrospun scaffolds achieve pore 
interconnectivity, but the pore size is very small.  Additionally, this research did not reveal 
an ability of the chondrocytes to move the fibers in order to migrate into the scaffolds (in 
fact, most cellular infiltration only occurred at open paths into the thickness/cross-section 
of the scaffolds).  A design proposition would be to actually punch uniformly distributed 
holes, on the 100 µm scale, into the hydrated scaffold (following cross-linking) to provide 
direct paths large enough for the cells to easily migrate through and into the thickness of 
the scaffold.  Exact geometries, and the consequential effects on the mechanical properties, 
would have to be investigated.  Additionally, cells could be sprayed into the scaffold 
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during the electrospinning fabrication process.  This would create a scaffold with cells 
already distributed within the scaffold; however, sterile conditions must be maintained. 
 On an additional design note, the tissue structure created in this research more 
closely resembles the superficial zone than the middle zone at this point.  Though the 
collagen fibers are randomly organized within the electrospun mat, the fibers are 
essentially only in two dimensions and run tangential to the mat surfaces.  Thought needs 
to be given as to how to create fibers that run perpendicular to the mat surfaces such that 
fibers are oriented randomly in three dimensions.   
 Several modifications can be made to the methods in future work to improve the 
analysis of GAGs and collagen, such as using the stains safranin-O or alcian blue for 
histochemical visualization of proteoglycans or picrosirius red to stain for collagen, or 
using SEM to visualize the cells on the surface of the scaffolds (to better show spherical 
versus elongated).  Additionally, instead of the ELISA for detection of collagen, several 
other techniques could be used including fluorescence immunostaining, probing the cells 
via in situ hybridization, or de novo synthesis with radioactive proline.  It could be possible 
that the cells need longer culture periods to degrade the existing scaffold, migrate into the 
scaffold, and replace the scaffold with their own ECM.  Though spherical cells were 
observed, the chondrocytes may need to be redifferentiated or freshly isolated 
chondrocytes could be used instead of chondrocytes cultured in monolayer prior to 
seeding.  The passaged cells could be combined with primary chondrocytes when seeded 
onto the scaffolds; such a co-culture approach has proven successful in increasing cartilage 
tissue formation [132].  Fabricating a scaffold out of another material or a mixture of 
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materials (i.e. natural and synthetic polymers) may stimulate the cells to make their own 
matrix; the type II collagen could be electrospun with another polymer, either from the 
same mixture or from multiple nozzles.  It has been shown that chondrocytes respond to 
decreases in the amount of matrix surrounding them by increasing their rate of matrix 
deposition [152].  Thus, tailoring the degradation rate (e.g. via cross-linking or modifying 
the materials) of the scaffold to be more rapid may cause the chondrocytes to respond with 
increased synthesis.   
 From the results of this research, there did not appear to be extensive cell-matrix 
interactions.  In articular cartilage, there is an interdependence between the two 
components in which the chondrocytes synthesize and degrade the ECM, and the ECM 
protects the chondrocytes from mechanical damage, transmits and stores such molecules as 
cytokines and growth factors for the chondrocytes, and acts as a signal transducer for the 
chondrocytes to help maintain their phenotype.  Though the chondrocytes attached to the 
surfaces of the scaffolds, the cell layers grew outward from the scaffolds and formed cell 
clusters in many areas.  There was very little cellular infiltration unless there was an 
opening of significant size (typically larger than the size of the cell).  The author believes 
that the first item to address given these results is to reevaluate the scaffold design.   
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APPENDIX A: Comparison of Materials Used In Vivo 
 
A summary of in vivo findings of the performance of various materials (autologous, 
natural, and synthetic) used in articular cartilage tissue engineering [36]. 
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APPENDIX B: Type II Collagen Extraction and Purification 
 
Protocol for Preparation of Type II Collagen from Fetal Bovine Articular Cartilage 
Expected yield: ~50:1 ratio of cartilage to CII if all goes well; therefore, a 150g bag of 
cartilage chips should yield ~3g of CII 
 
Cartilage Aquisition 
□ From fetal calf legs, remove articular cartilage from front and back limbs, all joints. 
Be careful to avoid collecting non-cartilaginous material (non-cartilaginous tissues 
contain other types of collagen that are difficult to separate from type II collagen). 
NOTE:  All operations must be performed at 4 ˚C, unless otherwise specified. 
 
Day 1 Date Amount 
□ Obtain the wet weight of cartilage.   
□ Cut cartilage into small pieces with a razor blade and blend in a Waring 
CB10T 3hp blender using ice and cold distilled water.  Three pulses at 
Maximum setting - one minute per pulse. 
  
□ Add an equal volume of cold (4˚C) 5 M guanidine/0.05 M Tris, pH 7.4 to 
the homogenate.   [Guanidine extracts proteoglycan] 
  
□ Check pH of entire mixture, pH to 7.4.   
□ Stir overnight in the cold.   
   
Day 2 Date Amount 
□ Centrifuge at 12250 g for 30 min at 4˚C.  Discard the supernate.   
□ Resuspend the cartilage pellet in cold distilled water and homogenize as 
before in blender if necessary. 
  
□ Collect the cartilage pellet by centrifugation (12250 g for 30 min at 4˚C) 
and wash with cold distilled water 3 more times.  Allow at least 1-2 hour of 
stirring in cold distilled water for each wash.   [It is important to remove 
guanidine completely, because guanidine may interfere with pepsin action 
at the next step] 
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□ Wash #2   
□ Wash #3   
□ Wash #4   
□ After the last wash, suspend the cartilage pellet in a suitable volume of cold 
0.5 M acetic acid (HAc), and adjust the pH of the suspension to 2.8 by 
using concentrated formic acid. 
  
□ Let solution equilibrate to room temperature.   
□ Add 2x pepsin (Sigma chemical company - highest quality available) –  
10 g/10 L of homogenate. 
Note: You can dissolve pepsin in a small volume of cold distilled water or 
0.5 M HAc for a few minutes and add to the cartilage homogenate with 
stirring.   [It is important to use pepsin as soon as it is dissolved because 
pepsin begins to autolyze as soon as it is in solution] 
  
□ Stir overnight in the cold.   
   
Day 3 Date Amount 
Appearance: after overnight, the suspension should be viscous with minimal 
cartilage pieces.   
□ Centrifuge (12250 g for 60 min in at 4˚C) and collect the viscous supernate 
containing solubilized collagen. 
If necessary, the cartilage pellet may be re-extracted with pepsin. 
  
□ Adjust the pH of the pepsin-extracted collagen supernate to 7.4:   
□ First add 10 mL/L of 1 M Tris, pH 7.4   
□ Use 10 M NaOH to bring the pH to 7.4.     
□ Add an equal volume of 5 M NaCl slowly and with good stirring   
□ Allow it to stand overnight at room temperature.   [This step precipitates 
collagen and also inactivates pepsin] 
  
   
Day 4 Date Amount 
□ Collect the collagen precipitate by centrifugation (12250 g for 60 min in at 
4˚C). 
  
□ Discard supernate.   
□ Dissolve the collagen precipitate in a suitable volume of 0.05M Tris/0.2 M 
NaCl, pH 7.4. 
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□ Stir overnight (or longer) in the cold.   
   
Day 5-7 Date Amount 
□ Dialyze the collagen solution vs. the 0.05M Tris/0.2 M NaCl, pH 7.4 buffer 
(at least 10 volumes) in the cold with stirring. 
  
□ 1st change   
□ 2nd change   
   
Day 8 Date Amount 
□ Centrifuge and collect supernate containing solubilized collagen.   
□ Add approximately 500 g of DE 52   
□ Stir gently in the cold overnight.   
   
Day 9 Date Amount 
□ Centrifuge and collect the supernate.  Discard the pellet.   
□ To the supernate, add while stirring the correct volume of 5 M NaCl to 
make the final concentration of NaCl to be 0.8 M, and the correct volume 
of HAc to make the final concentration of HAc to be 0.1 M.   [collagen will 
precipitate] – use Molarity Calculator 
  
□ Stir overnight in the cold.   
   
Day 10 Date Amount 
□ Centrifuge and collect the collagen precipitate.  Discard the supernate.   
□ Dissolve collagen precipitate in 0.1 M HAc.   
□ Stir overnight (or longer) in the cold.   
   
Day 11-15 Date Amount 
□ Centrifuge and collect the supernate.  Discard the pellet.   
□ Put collagen supernate into dialysis bags, and dialyze vs. 0.01 M Na2HPO4 
(10 volumes) in the cold with stirring.   [collagen will precipitate] 
  
□ 1st change   
□ 2nd change   
□ 3rd change   
□ 4th change   
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Day 16 Date Amount 
□ Centrifuge and collect collagen precipitate.   
□ Dissolve the precipitate in 0.1 M HAc.   
□ Stir overnight (or longer) in the cold.   
   
Day 17-23 Date Amount 
□ Centrifuge to obtain collagen solution.   
□ Place solution in dialysis bags and dialyze vs. 0.01 M HAc (at least 10 
volumes) in the cold with stirring. 
  
□ 1st change   
□ 2nd change   
□ 3rd change   
□ 4th change   
□ 5th change   
□ 6th change   
   
Day 24+ Date Amount 
□ Freeze collagen solution in ice cube trays.   
□ Place cubes in lyophilizer flasks and lyophilize until dry product is 
obtained. 
  
□ Test purity of collagen with SDS-PAGE.   
 
 
% Yield: # grams CII obtained  x  100%  =  ____________  x  100%  =  ____________% 
 # grams cartilage 
 
 ∴ ____________ ratio cartilage to type II collagen 
 
 
Chemicals to make on Day 1 
 
1 M Tris: 1 M x 121.14 MW x 1 L = 121.14 g, then fill to 1 L with dH2O 
 pH to 7.4 with HCl 
 
5 M Guanidine/0.05 M Tris: 5 M x 95.53 MW x 1 L = 477.65 g, then fill to 950 mL with dH2O 
  Add 50 mL 1 M Tris 
  pH to 7.4 
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APPENDIX C: Statistical Analysis 
 
Oneway Analysis of SEM Diameter By Concentration 
S
E
M
 D
ia
m
et
er
0
0.2
0.4
0.6
0.8
1
1.2
1.4
60 80 100 120
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 3.9574679 1.31916 70.2046 <.0001 
Error 236 4.4344806 0.01879  
C. Total 239 8.3919485  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 100 80 60 
120 0.000000 0.136717 0.261500 0.338467 
100 -0.13672 0.000000 0.124783 0.201750 
80 -0.2615 -0.12478 0.000000 0.076967 
60 -0.33847 -0.20175 -0.07697 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
2.58745 
Abs(Dif)-LSD 120 100 80 60 
120 -0.06476 0.071961 0.196744 0.273711 
100 0.071961 -0.06476 0.060028 0.136994 
80 0.196744 0.060028 -0.06476 0.012211 
60 0.273711 0.136994 0.012211 -0.06476 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Diameter By Technique for 60 mg/mL 
M
ea
su
re
m
en
t
0.05
0.1
0.15
0.2
0.25
0.3
0.35
ESEM Diameter SEM Diameter
Technique
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Technique 1 0.46538108 0.465381 199.7761 <.0001 
Error 118 0.27488252 0.002330   
C. Total 119 0.74026359   
Means Comparisons 
Dif=Mean[i]-Mean[j] ESEM Diameter SEM Diameter
ESEM Diameter 0.000000 0.124550
SEM Diameter -0.12455 0.000000
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
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q* 
1.98027 
Abs(Dif)-LSD ESEM Diameter SEM Diameter
ESEM Diameter -0.01745 0.107100
SEM Diameter 0.107100 -0.01745
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of SEM Pore Area By Concentration 
SE
M
 P
or
e 
Ar
ea
0
2
4
6
8
10
12
60 80 100 120
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 52.88905 17.6297 4.0904 0.0079 
Error 156 672.35568 4.3100  
C. Total 159 725.24474  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 120 80 60 
100 0.00000 0.25750 1.05165 1.41703 
120 -0.25750 0.00000 0.79415 1.15953 
80 -1.05165 -0.79415 0.00000 0.36538 
60 -1.41703 -1.15953 -0.36538 0.00000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
2.59695 
Abs(Dif)-LSD 100 120 80 60 
100 -1.20555 -0.94805 -0.15390 0.21147 
120 -0.94805 -1.20555 -0.41140 -0.04603 
80 -0.15390 -0.41140 -1.20555 -0.84018 
60 0.21147 -0.04603 -0.84018 -1.20555 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Pore Area By Technique for 60 mg/mL 
P
or
e 
A
re
a
0
1
2
3
4
5
6
7
8
ESEM Pore Area SEM Pore Area
Technique
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Technique 1 0.12090 0.12090 0.0438 0.8348
Error 78 215.27934 2.75999
C. Total 79 215.40024
Means Comparisons 
Dif=Mean[i]-Mean[j] SEM Pore Area ESEM Pore Area
SEM Pore Area 0.000000 0.077750
ESEM Pore Area -0.07775 0.000000
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
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q* 
1.99085 
Abs(Dif)-LSD SEM Pore Area ESEM Pore Area
SEM Pore Area -0.73957 -0.66182
ESEM Pore Area -0.66182 -0.73957
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Porosity (%) By Concentration (mg/mL) 
P
or
os
ity
 (%
)
80
82.5
85
87.5
90
92.5
95
100 120 60 80
Concentration (mg/mL)
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration (mg/mL) 3 48.57007 16.1900 1.2390 0.3578 
Error 8 104.53720 13.0672  
C. Total 11 153.10727  
Means Comparisons 
Dif=Mean[i]-Mean[j] 80 100 60 120 
80 0.00000 0.31333 1.86333 5.07667 
100 -0.31333 0.00000 1.55000 4.76333 
60 -1.86333 -1.55000 0.00000 3.21333 
120 -5.07667 -4.76333 -3.21333 0.00000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 80 100 60 120 
80 -9.45186 -9.13853 -7.58853 -4.37520 
100 -9.13853 -9.45186 -7.90186 -4.68853 
60 -7.58853 -7.90186 -9.45186 -6.23853 
120 -4.37520 -4.68853 -6.23853 -9.45186 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Permeability (D) By Concentration (mg/mL) 
Pe
rm
ea
bi
lit
y 
(D
)
0
0.001
0.002
0.003
0.004
100 120 60 80
Concentration (mg/mL)
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration (mg/mL) 3 0.00001497 0.000005 42.7107 <.0001 
Error 8 0.00000093 0.0000001  
C. Total 11 0.00001590  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 120 80 60 
100 0.000000 0.001253 0.002510 0.002820 
120 -0.00125 0.000000 0.001258 0.001567 
80 -0.00251 -0.00126 0.000000 0.000310 
60 -0.00282 -0.00157 -0.00031 0.000000 
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Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 120 80 60 
100 -0.00089 0.000359 0.001617 0.001926 
120 0.000359 -0.00089 0.000364 0.000674 
80 0.001617 0.000364 -0.00089 -0.00058 
60 0.001926 0.000674 -0.00058 -0.00089 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Diameter (um) By Concentration (mg/mL) – Permeability Data 
D
ia
m
et
er
 (u
m
)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
100 120 60 80
Concentration (mg/mL)
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration (mg/mL) 3 0.27523097 0.091744 19.4504 0.0005 
Error 8 0.03773442 0.004717  
C. Total 11 0.31296539  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 120 80 60 
100 0.000000 0.025773 0.300032 0.329035 
120 -0.02577 0.000000 0.274259 0.303262 
80 -0.30003 -0.27426 0.000000 0.029003 
60 -0.32903 -0.30326 -0.029 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 120 80 60 
100 -0.17958 -0.1538 0.120455 0.149458 
120 -0.1538 -0.17958 0.094682 0.123685 
80 0.120455 0.094682 -0.17958 -0.15057 
60 0.149458 0.123685 -0.15057 -0.17958 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Pore Area (um2) By Concentration (mg/mL) – Permeability Data 
P
or
e 
A
re
a 
(u
m
2)
0
0.0005
0.001
0.0015
0.002
0.0025
0.003
0.0035
100 120 60 80
Concentration (mg/mL)
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Concentration (mg/mL) 3 0.00000968 0.0000032 42.7156 <.0001
Error 8 0.00000060 7.5545e-8  
C. Total 11 0.00001029  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 120 80 60 
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Dif=Mean[i]-Mean[j] 100 120 80 60 
100 0.000000 0.001007 0.002019 0.002268 
120 -0.00101 0.000000 0.001012 0.001261 
80 -0.00202 -0.00101 0.000000 0.000249 
60 -0.00227 -0.00126 -0.00025 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 120 80 60 
100 -0.00072 0.000288 0.001300 0.001549 
120 0.000288 -0.00072 0.000293 0.000542 
80 0.001300 0.000293 -0.00072 -0.00047 
60 0.001549 0.000542 -0.00047 -0.00072 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 60 Thickness By Week # 
60
 T
hi
ck
ne
ss
0.5
0.55
0.6
0.65
0.7
0.75
0.8
0.85
0 2 4 6
Week #
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.02577267 0.008591 1.8280 0.2201
Error 8 0.03759600 0.004699
C. Total 11 0.06336867
Means Comparisons 
Dif=Mean[i]-Mean[j] 0 4 2 6 
0 0.000000 0.016667 0.067667 0.118333 
4 -0.01667 0.000000 0.051000 0.101667 
2 -0.06767 -0.051 0.000000 0.050667 
6 -0.11833 -0.10167 -0.05067 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 0 4 2 6 
0 -0.17925 -0.16258 -0.11158 -0.06091 
4 -0.16258 -0.17925 -0.12825 -0.07758 
2 -0.11158 -0.12825 -0.17925 -0.12858 
6 -0.06091 -0.07758 -0.12858 -0.17925 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 80 Thickness By Week # 
80
 T
hi
ck
ne
ss
1.05
1.1
1.15
1.2
1.25
1.3
1.35
0 2 4 6
Week #
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
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Source DF Sum of Squares Mean Square F Ratio Prob > F 
Week # 3 0.05366958 0.017890 2.5048 0.1330 
Error 8 0.05713867 0.007142  
C. Total 11 0.11080825  
Means Comparisons 
Dif=Mean[i]-Mean[j] 2 6 4 0 
2 0.000000 0.105667 0.131000 0.183667 
6 -0.10567 0.000000 0.025333 0.078000 
4 -0.131 -0.02533 0.000000 0.052667 
0 -0.18367 -0.078 -0.05267 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 2 6 4 0 
2 -0.22098 -0.11531 -0.08998 -0.03731 
6 -0.11531 -0.22098 -0.19564 -0.14298 
4 -0.08998 -0.19564 -0.22098 -0.16831 
0 -0.03731 -0.14298 -0.16831 -0.22098 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 100 Thickness By Week # 
10
0 
Th
ic
kn
es
s
0.5
0.6
0.7
0.8
0.9
1
0 2 4 6
Week #
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Week # 3 0.12236967 0.040790 4.3622 0.0425 
Error 8 0.07480533 0.009351  
C. Total 11 0.19717500  
Means Comparisons 
Dif=Mean[i]-Mean[j] 4 2 6 0 
4 0.000000 0.135667 0.199000 0.275333 
2 -0.13567 0.000000 0.063333 0.139667 
6 -0.199 -0.06333 0.000000 0.076333 
0 -0.27533 -0.13967 -0.07633 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 4 2 6 0 
4 -0.25284 -0.11717 -0.05384 0.022492 
2 -0.11717 -0.25284 -0.18951 -0.11317 
6 -0.05384 -0.18951 -0.25284 -0.17651 
0 0.022492 -0.11317 -0.17651 -0.25284 
Positive values show pairs of means that are significantly different. 
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Oneway Analysis of 120 Thickness By Week # 
12
0 
Th
ic
kn
es
s
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
0 2 4 6
Week #
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.16257620 0.054192 1.8794 0.2114
Error 8 0.23067361 0.028834  
C. Total 11 0.39324981  
Means Comparisons 
Dif=Mean[i]-Mean[j] 2 4 6 0 
2 0.000000 0.162300 0.225967 0.319300 
4 -0.1623 0.000000 0.063667 0.157000 
6 -0.22597 -0.06367 0.000000 0.093333 
0 -0.3193 -0.157 -0.09333 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 2 4 6 0 
2 -0.444 -0.2817 -0.21803 -0.1247 
4 -0.2817 -0.444 -0.38033 -0.287 
6 -0.21803 -0.38033 -0.444 -0.35066 
0 -0.1247 -0.287 -0.35066 -0.444 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 0 Thickness By Concentration 
W
ee
k 
0 
Th
ic
kn
es
s
0.4
0.5
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.73946892 0.246490 21.7502 0.0003 
Error 8 0.09066200 0.011333  
C. Total 11 0.83013092  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 80 60 100 
120 0.000000 0.107667 0.529333 0.558667 
80 -0.10767 0.000000 0.421667 0.451000 
60 -0.52933 -0.42167 0.000000 0.029333 
100 -0.55867 -0.451 -0.02933 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 120 80 60 100 
120 -0.27835 -0.17069 0.250981 0.280314 
80 -0.17069 -0.27835 0.143314 0.172648 
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q* 
60 0.250981 0.143314 -0.27835 -0.24902 
100 0.280314 0.172648 -0.24902 -0.27835 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 2 Thickness By Concentration 
W
ee
k 
2 
Th
ic
kn
es
s
0.8
1
1.2
1.4
1.6
1.8
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 1.6301441 0.543381 161.8796 <.0001 
Error 8 0.0268536 0.003357  
C. Total 11 1.6569977  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 80 100 60 
120 0.000000 0.243300 0.738300 0.916300 
80 -0.2433 0.000000 0.495000 0.673000 
100 -0.7383 -0.495 0.000000 0.178000 
60 -0.9163 -0.673 -0.178 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 120 80 100 60 
120 -0.15149 0.091810 0.586810 0.764810 
80 0.091810 -0.15149 0.343510 0.521510 
100 0.586810 0.343510 -0.15149 0.026510 
60 0.764810 0.521510 0.026510 -0.15149 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 4 Thickness By Concentration 
W
ee
k 
4 
Th
ic
kn
es
s
0.7
0.8
1
1.1
1.3
1.5
1.6
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.8214430 0.273814 10.0942 0.0043 
Error 8 0.2170080 0.027126  
C. Total 11 1.0384510  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 80 100 60 
120 0.000000 0.212000 0.440333 0.703000 
80 -0.212 0.000000 0.228333 0.491000 
100 -0.44033 -0.22833 0.000000 0.262667 
60 -0.703 -0.491 -0.26267 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
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q* 
3.20238 
Abs(Dif)-LSD 120 80 100 60 
120 -0.43065 -0.21865 0.009688 0.272355 
80 -0.21865 -0.43065 -0.20231 0.060355 
100 0.009688 -0.20231 -0.43065 -0.16798 
60 0.272355 0.060355 -0.16798 -0.43065 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 6 Thickness By Concentration 
W
ee
k 
6 
Th
ic
kn
es
s
0.5
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 1.1323263 0.377442 45.9665 <.0001 
Error 8 0.0656900 0.008211  
C. Total 11 1.1980163  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 80 100 60 
120 0.000000 0.123000 0.575667 0.741000 
80 -0.123 0.000000 0.452667 0.618000 
100 -0.57567 -0.45267 0.000000 0.165333 
60 -0.741 -0.618 -0.16533 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 120 80 100 60 
120 -0.23694 -0.11394 0.338730 0.504064 
80 -0.11394 -0.23694 0.215730 0.381064 
100 0.338730 0.215730 -0.23694 -0.0716 
60 0.504064 0.381064 -0.0716 -0.23694 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 0 Eq Stiffness By Concentration 
W
ee
k 
0 
E
q 
M
od
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us
0.03
0.04
0.05
0.06
0.07
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.00044189 0.000147 2.0375 0.1872 
Error 8 0.00057833 0.000072  
C. Total 11 0.00102022  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 60 120 80 
100 0.000000 0.009267 0.014433 0.015233 
60 -0.00927 0.000000 0.005167 0.005967 
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Dif=Mean[i]-Mean[j] 100 60 120 80 
120 -0.01443 -0.00517 0.000000 0.000800 
80 -0.01523 -0.00597 -0.0008 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 60 120 80 
100 -0.02223 -0.01296 -0.0078 -0.007 
60 -0.01296 -0.02223 -0.01706 -0.01626 
120 -0.0078 -0.01706 -0.02223 -0.02143 
80 -0.007 -0.01626 -0.02143 -0.02223 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 2 Eq Stiffness By Concentration 
W
ee
k 
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E
q 
M
od
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0
0.025
0.05
0.075
0.1
0.125
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.00531321 0.001771 3.6573 0.0633 
Error 8 0.00387406 0.000484  
C. Total 11 0.00918727  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 120 80 60 
100 0.000000 0.034033 0.034233 0.059167 
120 -0.03403 0.000000 0.000200 0.025133 
80 -0.03423 -0.0002 0.000000 0.024933 
60 -0.05917 -0.02513 -0.02493 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 120 80 60 
100 -0.05754 -0.02351 -0.02331 0.001627 
120 -0.02351 -0.05754 -0.05734 -0.03241 
80 -0.02331 -0.05734 -0.05754 -0.03261 
60 0.001627 -0.03241 -0.03261 -0.05754 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 4 Eq Stiffness By Concentration 
W
ee
k 
4 
E
q 
M
od
ul
us
0
0.025
0.05
0.075
0.1
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.00204270 0.000681 1.7441 0.2353 
Error 8 0.00312322 0.000390  
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Source DF Sum of Squares Mean Square F Ratio Prob > F 
C. Total 11 0.00516592  
Means Comparisons 
Dif=Mean[i]-Mean[j] 100 120 80 60 
100 0.000000 0.011467 0.023833 0.034767 
120 -0.01147 0.000000 0.012367 0.023300 
80 -0.02383 -0.01237 0.000000 0.010933 
60 -0.03477 -0.0233 -0.01093 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 120 80 60 
100 -0.05166 -0.0402 -0.02783 -0.0169 
120 -0.0402 -0.05166 -0.0393 -0.02836 
80 -0.02783 -0.0393 -0.05166 -0.04073 
60 -0.0169 -0.02836 -0.04073 -0.05166 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 6 Eq Stiffness By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.00068615 0.000229 7.1653 0.0118 
Error 8 0.00025536 0.000032  
C. Total 11 0.00094151  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 80 60 100 
120 0.000000 0.015133 0.015567 0.020000 
80 -0.01513 0.000000 0.000433 0.004867 
60 -0.01557 -0.00043 0.000000 0.004433 
100 -0.02 -0.00487 -0.00443 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 120 80 60 100 
120 -0.01477 0.000361 0.000794 0.005227 
80 0.000361 -0.01477 -0.01434 -0.00991 
60 0.000794 -0.01434 -0.01477 -0.01034 
100 0.005227 -0.00991 -0.01034 -0.01477 
Positive values show pairs of means that are significantly different. 
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Oneway Analysis of 60 Eq Stiffness By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.00168734 0.000562 7.1684 0.0118
Error 8 0.00062770 0.000078
C. Total 11 0.00231504
Means Comparisons 
Dif=Mean[i]-Mean[j] 0 2 4 6 
0 0.000000 0.021467 0.024700 0.031800 
2 -0.02147 0.000000 0.003233 0.010333 
4 -0.0247 -0.00323 0.000000 0.007100 
6 -0.0318 -0.01033 -0.0071 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 0 2 4 6 
0 -0.02316 -0.00169 0.001539 0.008639 
2 -0.00169 -0.02316 -0.01993 -0.01283 
4 0.001539 -0.01993 -0.02316 -0.01606 
6 0.008639 -0.01283 -0.01606 -0.02316 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 80 Eq Stiffness By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.00196132 0.000654 2.8139 0.1076
Error 8 0.00185867 0.000232
C. Total 11 0.00381999
Means Comparisons 
Dif=Mean[i]-Mean[j] 2 0 4 6 
2 0.000000 0.009433 0.017233 0.034833 
0 -0.00943 0.000000 0.007800 0.025400 
4 -0.01723 -0.0078 0.000000 0.017600 
6 -0.03483 -0.0254 -0.0176 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 2 0 4 6 
2 -0.03985 -0.03042 -0.02262 -0.00502 
0 -0.03042 -0.03985 -0.03205 -0.01445 
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q* 
4 -0.02262 -0.03205 -0.03985 -0.02225 
6 -0.00502 -0.01445 -0.02225 -0.03985 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 100 Eq Modulus By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.00843958 0.002813 4.9665 0.0311
Error 8 0.00453143 0.000566
C. Total 11 0.01297101
Means Comparisons 
Dif=Mean[i]-Mean[j] 2 4 0 6 
2 0.000000 0.027633 0.028433 0.073933 
4 -0.02763 0.000000 0.000800 0.046300 
0 -0.02843 -0.0008 0.000000 0.045500 
6 -0.07393 -0.0463 -0.0455 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 2 4 0 6 
2 -0.06223 -0.0346 -0.0338 0.011703 
4 -0.0346 -0.06223 -0.06143 -0.01593 
0 -0.0338 -0.06143 -0.06223 -0.01673 
6 0.011703 -0.01593 -0.01673 -0.06223 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 120 Eq Stiffness By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.00064230 0.000214 2.1063 0.1778
Error 8 0.00081318 0.000102
C. Total 11 0.00145548
Means Comparisons 
Dif=Mean[i]-Mean[j] 2 4 0 6 
2 0.000000 0.005067 0.008833 0.019900 
4 -0.00507 0.000000 0.003767 0.014833 
0 -0.00883 -0.00377 0.000000 0.011067 
6 -0.0199 -0.01483 -0.01107 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
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q* 
3.20238 
Abs(Dif)-LSD 2 4 0 6 
2 -0.02636 -0.0213 -0.01753 -0.00646 
4 -0.0213 -0.02636 -0.0226 -0.01153 
0 -0.01753 -0.0226 -0.02636 -0.0153 
6 -0.00646 -0.01153 -0.0153 -0.02636 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Peak Stress (MPa) By Concentration (mg/mL) 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration (mg/mL) 3 0.08400719 0.028002 48.9071 <.0001 
Error 12 0.00687075 0.000573   
C. Total 15 0.09087794   
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 120 80 100 
60 0.000000 0.024250 0.125250 0.177250 
120 -0.02425 0.000000 0.101000 0.153000 
80 -0.12525 -0.101 0.000000 0.052000 
100 -0.17725 -0.153 -0.052 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
2.96883 
Abs(Dif)-LSD 60 120 80 100 
60 -0.05023 -0.02598 0.075018 0.127018 
120 -0.02598 -0.05023 0.050768 0.102768 
80 0.075018 0.050768 -0.05023 0.001768 
100 0.127018 0.102768 0.001768 -0.05023 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Strain at Break (%) By Concentration (mg/mL) 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration (mg/mL) 3 6238.5525 2079.52 28.2267 <.0001 
Error 12 884.0650 73.67   
C. Total 15 7122.6175   
Means Comparisons 
Dif=Mean[i]-Mean[j] 80 60 100 120 
80 0.0000 24.0750 28.1250 55.6500 
60 -24.0750 0.0000 4.0500 31.5750 
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Dif=Mean[i]-Mean[j] 80 60 100 120 
100 -28.1250 -4.0500 0.0000 27.5250 
120 -55.6500 -31.5750 -27.5250 0.0000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
2.96883 
Abs(Dif)-LSD 80 60 100 120 
80 -18.0186 6.0564 10.1064 37.6314 
60 6.0564 -18.0186 -13.9686 13.5564 
100 10.1064 -13.9686 -18.0186 9.5064 
120 37.6314 13.5564 9.5064 -18.0186 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Modulus (MPa) By Concentration (mg/mL) 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Concentration (mg/mL) 3 0.29920369 0.099735 26.2271 <.0001
Error 12 0.04563275 0.003803  
C. Total 15 0.34483644  
Means Comparisons 
Dif=Mean[i]-Mean[j] 120 60 80 100 
120 0.000000 0.096000 0.303500 0.321750 
60 -0.096 0.000000 0.207500 0.225750 
80 -0.3035 -0.2075 0.000000 0.018250 
100 -0.32175 -0.22575 -0.01825 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
2.96883 
Abs(Dif)-LSD 120 60 80 100 
120 -0.12945 -0.03345 0.174045 0.192295 
60 -0.03345 -0.12945 0.078045 0.096295 
80 0.174045 0.078045 -0.12945 -0.1112 
100 0.192295 0.096295 -0.1112 -0.12945 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 2 Cell # By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 4.21282e10 1.4043e10 10.5881 0.0037 
Error 8 1.06103e10 1.32628e9  
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Source DF Sum of Squares Mean Square F Ratio Prob > F 
C. Total 11 5.27385e10  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 100 80 120 
60 0 89735 101387 166254 
100 -89735 0 11651 76519 
80 -101387 -11651 0 64868 
120 -166254 -76519 -64868 0 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 60 100 80 120 
60 -95223.7 -5488.4 6162.9 71030.8 
100 -5488.4 -95223.7 -83572.4 -18704.6 
80 6162.9 -83572.4 -95223.7 -30355.8 
120 71030.8 -18704.6 -30355.8 -95223.7 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 4 Cell # By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 3.51814e10 1.1727e10 7.3339 0.0110 
Error 8 1.27922e10 1.59903e9  
C. Total 11 4.79736e10  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 100 80 120 
60 0 70261 89927 151763 
100 -70261 0 19666 81502 
80 -89927 -19666 0 61836 
120 -151763 -81502 -61836 0 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 60 100 80 120 
60 -104557 -34296 -14630 47206 
100 -34296 -104557 -84891 -23056 
80 -14630 -84891 -104557 -42722 
120 47206 -23056 -42722 -104557 
Positive values show pairs of means that are significantly different. 
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Oneway Analysis of Week 6 Cell # By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 5.8741e+10 1.958e+10 49.2456 0.0013 
Error 4 1590422455 397605614  
C. Total 7 6.03314e10  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 80 100 120 
60 0 61834 87761 233548 
80 -61834 0 25927 171714 
100 -87761 -25927 0 145788 
120 -233548 -171714 -145788 0 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
4.07087 
Abs(Dif)-LSD 60 80 100 120 
60 -81173 -19339 6587 152375 
80 -19339 -81173 -55247 90541 
100 6587 -55247 -81173 64614 
120 152375 90541 64614 -81173 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 60 Cell # By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 2 8855489021 4.42774e9 1.2524 0.3623
Error 5 1.76771e10 3.53543e9
C. Total 7 2.65326e10
Means Comparisons 
Dif=Mean[i]-Mean[j] 6 4 2
6 0.0 74151.8 79188.2
4 -74151.8 0.0 5036.4
2 -79188.2 -5036.4 0.0
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.25387 
Abs(Dif)-LSD 6 4 2
6 -193473 -102464 -97428
4 -102464 -157970 -152934
2 -97428 -152934 -157970
Positive values show pairs of means that are significantly different. 
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Oneway Analysis of 80 Cell # By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 2 1.87212e10 9.36061e9 17.7091 0.0054
Error 5 2642875222 528575044
C. Total 7 2.13641e10
Means Comparisons 
Dif=Mean[i]-Mean[j] 6 4 2
6 0 102245 118741
4 -102245 0 16496
2 -118741 -16496 0
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.25387 
Abs(Dif)-LSD 6 4 2
6 -74808.9 33954.4 50450.0
4 33954.4 -61081.2 -44585.6
2 50450.0 -44585.6 -61081.2
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 100 Cell # By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 2 8023554493 4.01178e9 4.5757 0.0742
Error 5 4383773201 876754640
C. Total 7 1.24073e10
Means Comparisons 
Dif=Mean[i]-Mean[j] 6 4 2
6 0.0 56652.3 81163.0
4 -56652.3 0.0 24510.6
2 -81163.0 -24510.6 0.0
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.25387 
Abs(Dif)-LSD 6 4 2
6 -96347.1 -31300.2 -6789.5
4 -31300.2 -78667.1 -54156.5
2 -6789.5 -54156.5 -78667.1
Positive values show pairs of means that are significantly different. 
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Oneway Analysis of 120 Cell # By Week # 
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Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Week # 2 578815023 289407512 5.0047 0.0640 
Error 5 289133546 57826709  
C. Total 7 867948570  
Means Comparisons 
Dif=Mean[i]-Mean[j] 4 6 2
4 0.0 7633.2 19527.8
6 -7633.2 0.0 11894.6
2 -19527.8 -11894.6 0.0
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.25387 
Abs(Dif)-LSD 4 6 2
4 -20203.1 -14954.5 -675.3
6 -14954.5 -24743.7 -10693.2
2 -675.3 -10693.2 -20203.1
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 0 GAG By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squaes Mean Square F Ratio Prob > F 
Concentration 3 0.37112887 0.123710 3.8958 0.0551 
Error 8 0.25403471 0.031754  
C. Total 11 0.62516358  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 100 80 120 
60 0.000000 0.073048 0.376239 0.392261 
100 -0.07305 0.000000 0.303191 0.319213 
80 -0.37624 -0.30319 0.000000 0.016022 
120 -0.39226 -0.31921 -0.01602 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 60 100 80 120 
60 -0.46594 -0.39289 -0.0897 -0.07368 
100 -0.39289 -0.46594 -0.16275 -0.14673 
80 -0.0897 -0.16275 -0.46594 -0.44992 
120 -0.07368 -0.14673 -0.44992 -0.46594 
Positive values show pairs of means that are significantly different. 
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Oneway Analysis of Week 2 GAG By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.16558488 0.055195 3.2879 0.0792 
Error 8 0.13429777 0.016787  
C. Total 11 0.29988265  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 100 80 120 
60 0.000000 0.014583 0.219451 0.260881 
100 -0.01458 0.000000 0.204868 0.246297 
80 -0.21945 -0.20487 0.000000 0.041430 
120 -0.26088 -0.2463 -0.04143 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 60 100 80 120 
60 -0.33878 -0.3242 -0.11933 -0.0779 
100 -0.3242 -0.33878 -0.13391 -0.09248 
80 -0.11933 -0.13391 -0.33878 -0.29735 
120 -0.0779 -0.09248 -0.29735 -0.33878 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 4 GAG By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.22316000 0.074387 2.2756 0.1568 
Error 8 0.26151516 0.032689  
C. Total 11 0.48467517  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 80 100 120 
60 0.000000 0.118975 0.162049 0.377216 
80 -0.11898 0.000000 0.043074 0.258240 
100 -0.16205 -0.04307 0.000000 0.215167 
120 -0.37722 -0.25824 -0.21517 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 60 80 100 120 
60 -0.47275 -0.35377 -0.3107 -0.09553 
80 -0.35377 -0.47275 -0.42968 -0.21451 
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q* 
100 -0.3107 -0.42968 -0.47275 -0.25758 
120 -0.09553 -0.21451 -0.25758 -0.47275 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 6 GAG By Concentration 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.10779934 0.035933 1.3286 0.3313 
Error 8 0.21637248 0.027047  
C. Total 11 0.32417182  
Means Comparisons 
Dif=Mean[i]-Mean[j] 60 100 120 80 
60 0.000000 0.143309 0.196455 0.255994 
100 -0.14331 0.000000 0.053147 0.112686 
120 -0.19646 -0.05315 0.000000 0.059539 
80 -0.25599 -0.11269 -0.05954 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 60 100 120 80 
60 -0.43001 -0.28671 -0.23356 -0.17402 
100 -0.28671 -0.43001 -0.37687 -0.31733 
120 -0.23356 -0.37687 -0.43001 -0.37048 
80 -0.17402 -0.31733 -0.37048 -0.43001 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 60 GAG By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.02715937 0.009053 0.1446 0.9303
Error 8 0.50077633 0.062597
C. Total 11 0.52793570
Means Comparisons 
Dif=Mean[i]-Mean[j] 0 4 6 2 
0 0.000000 0.048926 0.089364 0.128138 
4 -0.04893 0.000000 0.040438 0.079212 
6 -0.08936 -0.04044 0.000000 0.038774 
2 -0.12814 -0.07921 -0.03877 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
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q* 
3.20238 
Abs(Dif)-LSD 0 4 6 2 
0 -0.65419 -0.60526 -0.56483 -0.52605 
4 -0.60526 -0.65419 -0.61375 -0.57498 
6 -0.56483 -0.61375 -0.65419 -0.61542 
2 -0.52605 -0.57498 -0.61542 -0.65419 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 80 GAG By Week # 
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.08172200 0.027241 2.4740 0.1360
Error 8 0.08808536 0.011011
C. Total 11 0.16980736
Means Comparisons 
Dif=Mean[i]-Mean[j] 4 6 2 0 
4 0.000000 0.177457 0.179688 0.208338 
6 -0.17746 0.000000 0.002231 0.030880 
2 -0.17969 -0.00223 0.000000 0.028650 
0 -0.20834 -0.03088 -0.02865 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 4 6 2 0 
4 -0.27437 -0.09691 -0.09468 -0.06603 
6 -0.09691 -0.27437 -0.27214 -0.24349 
2 -0.09468 -0.27214 -0.27437 -0.24572 
0 -0.06603 -0.24349 -0.24572 -0.27437 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 100 GAG By Week # 
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0 2 4 6
Week #
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.04693408 0.015645 1.2648 0.3499
Error 8 0.09895725 0.012370  
C. Total 11 0.14589133  
Means Comparisons 
Dif=Mean[i]-Mean[j] 0 2 4 6 
0 0.000000 0.069673 0.137927 0.159625 
2 -0.06967 0.000000 0.068253 0.089951 
4 -0.13793 -0.06825 0.000000 0.021698 
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Dif=Mean[i]-Mean[j] 0 2 4 6 
6 -0.15962 -0.08995 -0.0217 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 0 2 4 6 
0 -0.29081 -0.22113 -0.15288 -0.13118 
2 -0.22113 -0.29081 -0.22255 -0.20086 
4 -0.15288 -0.22255 -0.29081 -0.26911 
6 -0.13118 -0.20086 -0.26911 -0.29081 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 120 GAG By Week # 
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Week #
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 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.03315500 0.011052 0.4956 0.6954
Error 8 0.17840118 0.022300
C. Total 11 0.21155618
Means Comparisons 
Dif=Mean[i]-Mean[j] 6 2 0 4 
6 0.000000 0.103200 0.106441 0.140322 
2 -0.1032 0.000000 0.003242 0.037122 
0 -0.10644 -0.00324 0.000000 0.033881 
4 -0.14032 -0.03712 -0.03388 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 6 2 0 4 
6 -0.39046 -0.28726 -0.28402 -0.25014 
2 -0.28726 -0.39046 -0.38722 -0.35334 
0 -0.28402 -0.38722 -0.39046 -0.35658 
4 -0.25014 -0.35334 -0.35658 -0.39046 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of Week 6 Type II Collagen  By Concentration 
W
ee
k 
6 
C
I
-0.002
0
0.002
0.004
0.006
0.008
100 120 60 80
Concentration
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 3 0.00008827 0.000029 94.8396 <.0001 
Error 8 0.00000248 0.000000  
C. Total 11 0.00009076  
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Means Comparisons 
Dif=Mean[i]-Mean[j] 100 80 60 120 
100 0.000000 0.005987 0.006385 0.006385 
80 -0.00599 0.000000 0.000398 0.000398 
60 -0.00638 -0.0004 0.000000 0.000000 
120 -0.00638 -0.0004 0.000000 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 100 80 60 120 
100 -0.00146 0.004531 0.004928 0.004928 
80 0.004531 -0.00146 -0.00106 -0.00106 
60 0.004928 -0.00106 -0.00146 -0.00146 
120 0.004928 -0.00106 -0.00146 -0.00146 
Positive values show pairs of means that are significantly different. 
 
Oneway Analysis of 100 Type II Collagen By Week # 
10
0 
C
I
-0.002
0
0.002
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0 2 4 6
Week #
All Pairs
Tukey-Kramer
 0.05  
Oneway Anova 
Source DF Sum of Squares Mean Square F Ratio Prob > F
Week # 3 0.00007229 0.000024 13.5837 0.0017
Error 8 0.00001419 0.000002
C. Total 11 0.00008648
Means Comparisons 
Dif=Mean[i]-Mean[j] 6 4 2 0 
6 0.000000 0.004077 0.005903 0.006114 
4 -0.00408 0.000000 0.001826 0.002037 
2 -0.0059 -0.00183 0.000000 0.000211 
0 -0.00611 -0.00204 -0.00021 0.000000 
Alpha=0.05 
Comparisons for all pairs using Tukey-Kramer HSD 
q* 
3.20238 
Abs(Dif)-LSD 6 4 2 0 
6 -0.00348 0.000594 0.002421 0.002632 
4 0.000594 -0.00348 -0.00166 -0.00145 
2 0.002421 -0.00166 -0.00348 -0.00327 
0 0.002632 -0.00145 -0.00327 -0.00348 
Positive values show pairs of means that are significantly different. 
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APPENDIX D: Stress Relaxation Data 
 
Extension versus time and load versus time curves used to construct the equilibrium 
stress versus strain curves in the stress relaxation mechanical testing. 
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100 mg/ml 2 wk Sample 1
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100 mg/ml 6 wk Sample 1
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Equilibrium stress versus strain curves used to determine the equilibrium stiffness in 
the stress relaxation mechanical testing. 
 
WEEK 0 
Cartilage
Sample
y = 0.4677x - 0.0499
R2 = 0.9753
y = 1.3495x - 0.0527
R2 = 0.9826
y = -0.0068x + 0.076
R2 = 0.5619
0.000
0.050
0.100
0.150
0.200
0.250
0.300
0.350
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
Week 0
60 mg/mL
y = 0.0593x - 0.0024
R2 = 0.9952
y = 0.0427x + 0.0015
R2 = 0.998
y = 0.0374x + 0.0018
R2 = 0.9973
0.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
159 
Week 0
80 mg/mL
y = 0.0462x + 0.0013
R2 = 0.997
y = 0.0412x + 0.0018
R2 = 0.9943
y = 0.0341x + 0.0032
R2 = 0.9992
0.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
Week 0
100 mg/mL
y = 0.0478x + 0.0026
R2 = 0.9856
y = 0.0626x - 0.0003
R2 = 0.9891
y = 0.0568x + 0.0007
R2 = 0.9934
0.000
0.005
0.010
0.015
0.020
0.025
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
Week 0
120 mg/mL
y = 0.0481x + 0.002
R2 = 0.9957
y = 0.0323x + 0.0035
R2 = 0.9996
y = 0.0435x + 0.0021
R2 = 0.9961
0.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
 
WEEK 2 
Week 2
60 mg/mL
y = 0.0249x - 0.0002
R2 = 0.9993
y = 0.0361x - 0.0021
R2 = 0.9948
y = 0.014x + 0.0015
R2 = 0.9932
0.000
0.001
0.002
0.003
0.004
0.005
0.006
0.007
0.008
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
160 
Week 2
80 mg/mL
y = 0.0277x + 0.0024
R2 = 0.9638
y = 0.0407x + 0.0004
R2 = 0.9758
y = 0.0814x - 0.0068
R2 = 0.9749
0.000
0.005
0.010
0.015
0.020
0.025
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
Week 2
100 mg/mL
y = 0.0965x - 0.0051
R2 = 0.9568
y = 0.0521x + 0.0006
R2 = 0.9405
y = 0.1039x - 0.0059
R2 = 0.9531
0.000
0.010
0.020
0.030
0.040
0.050
0.060
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
Week 2
120 mg/mL
y = 0.0417x + 0.0022
R2 = 0.9691
y = 0.0405x + 0.0022
R2 = 0.9842
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WEEK 4 
Week 4
60 mg/mL
y = 0.0189x + 0.0002
R2 = 0.9973
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Week 4
80 mg/mL
y = 0.0439x - 0.002
R2 = 0.9871
y = 0.0276x + 0.0003
R2 = 0.9802
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Week 4
100 mg/mL
y = 0.0994x - 0.0056
R2 = 0.9468
y = 0.0419x + 0.0011
R2 = 0.981
y = 0.0283x + 0.0017
R2 = 0.9909
0.000
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.00 0.05 0.10 0.15 0.20 0.25 0.30
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
 
Week 4
120 mg/mL
y = 0.0387x + 0.002
R2 = 0.9863
y = 0.0461x + 0.0014
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WEEK 6 
Week 6
60 mg/mL
y = 0.0075x + 0.0017
R2 = 0.9461
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Week 6
80 mg/mL
y = 0.0179x + 0.0018
R2 = 0.9935
y = 0.0164x + 0.0014
R2 = 0.9917
y = 0.011x + 0.002
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Week 6
100 mg/mL
y = 0.0092x + 0.0022
R2 = 0.9998
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Week 6
120 mg/mL
y = 0.0255x + 0.0023
R2 = 0.9897
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